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Abstract 
Mycobacterium tuberculosis is the causative agent of tuberculosis, a disease which causes 
approximately 2 million deaths each year. Despite extensive research on tuberculosis and M. 
tuberculosis, little is understood of the mechanisms of pathogenicity of the organism. The genome of 
M. tuberculosis contains five ESAT-6 gene cluster regions, each of which contains genes encoding 
proteins involved in the formation of a dedicated protein secretion system. Included in these regions 
are genes encoding exported T-cell antigens, serine proteases, ATP-binding proteins and other 
membrane-associated proteins. Although it is known that some of these secretion systems are 
involved in virulence and phagosomal escape of M. tuberculosis, and that deletion thereof causes 
attenuation of the organism, the structure, substrates and functions of the systems are largely 
unknown. Understanding the structure of the ESX secretion systems will advance our understanding 
of the mechanisms of mycobacterial pathogenicity and provide clues to ways in which to interfere with 
these virulence mechanisms.  
The ESAT-6 gene cluster region 3, encoding the ESX-3 secretion machinery, is the only ESAT-6 gene 
cluster region which is essential for the in vitro growth of M. tuberculosis. It is however not required for 
the growth of the saprophytic mycobacterium M. smegmatis. In this study we have identified protein-
protein interactions within the ESX-3 secretion system, using the Mycobacterial – Protein Fragment 
Complementation (M-PFC) mycobacterial two-hybrid system, and created a model of the M. 
tuberculosis ESX-3 secretion system. According to this model, the EsxG-EsxH and PE5-PPE4 
substrate protein complexes bind to the same components of the ESX-3 secretion machinery and are 
secreted via the same mechanism.  A knock-out of the ESX-3 secretion system in M. smegmatis was 
generated by homologous recombination to allow further research into the functions and properties of 
this secretion system. This knock-out was used, together with wild-type M. smegmatis, to investigate 
the secretion of the M. tuberculosis EsxH protein by the M. smegmatis ESX-3 secretion system. 
The ESX-3 secretion system interactome may serve as a model for the ESX secretion systems and 
assist in our understanding of this secretion machinery which is key to the virulence and survival of M. 
tuberculosis and other pathogenic mycobacteria. Improved understanding of these mechanisms and 
their role in pathogenicity and survival may provide means of interfering with the secretion machinery, 
potentially leading to developments in the prevention and treatment of tuberculosis disease. 
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Abstrak 
Tuberkulose, wat veroorsaak word deur Mycobacterium tuberculosis, eis jaarliks ongeveer 2 miljoen 
lewens. Ten spyte van uitgebreide navorsing oor tuberkulose en M. tuberculosis is min bekend oor die 
meganismes van patogenisiteit van díe organisme. Die genoom van M. tuberculosis bevat vyf ESAT-6 
geen groep gebiede wat elk proteïene kodeer wat ‘n toegewyde sekresie sisteem vorm. Ingesluit in elk 
van díe geen groep gebiede is gene wat T-sel antigene, serien proteases, ATP-bindingsproteïene en 
ander membraan-geassosieërde proteïene kodeer. Alhoewel dit bekend is dat sekere van hierdie 
sekresie sisteme betrokke is by virulensie en fagosoom-ontsnapping, en dat delesie daarvan die 
organisme attenueer, is die struktuur, substrate en funksies van die sisteme grootliks onbekend. 
Kennis van die struktuur van die ESX sekresie sisteme sal ons verstaan van die meganismes van 
mikobakteriele patogenisiteit verbeter en leidrade verskaf na maniere om in te meng by díe 
meganismes van virulensie.  
Die ESAT-6 geen groep gebied 3, wat die ESX-3 sekresie sisteem kodeer, is die enigste ESAT-6 
geen groep gebied wat noodsaaklik is vir die in vitro groei van M. tuberculosis. Dit is egter nie nodig vir 
die groei van die saprofitiese mikobakterium M. smegmatis nie. In hierdie studie het ons proteïen-
proteïen interaksies van die ESX-3 sekresie sisteem geïdentifiseer, deur middel van die 
Mikobakteriële - Proteïen Fragment Komplementasie (M-PFC) mikobacteriële twee-hibriede stelsel. 
Die interaksies is gebruik om ‘n model van die M. tuberculosis ESX-3 sekresie sisteem te skep. 
Volgens díe model bind die EsxG-EsxH en PE5-PPE4 substraat proteïen komplekse aan dieselfde 
komponente van die ESX-3 sekresie apparaat en word deur dieselfde meganisme uitgevoer. ‘n 
uitklopmutant van die ESX-3 sekresie sisteem word deur homoloë rekombinasie in M. smegmatis 
gegenereer om verdere ondersoeke na die funksies en eienskappe van hierdie sekresie sisteem in 
staat te stel. Hierdie uitklopmutant is tesame met die wilde-tipe M. smegmatis gebruik om die sekresie 
van die M. tuberculosis EsxH proteïen deur die M. smegmatis ESX-3 sekresie sisteem te ondersoek. 
Die ESX-3 sekresie sisteem interaktoom kan dien as ‘n model vir die ESX sekresie sisteme om te help 
om ons kennis van hierdie sekresie apparaat, wat belangrik is vir die virulensie en oorlewing van M. 
tuberculosis en ander patogeniese mikobakterieë, te verbeter. Kennis van hierdie meganismes en hul 
rol in patogenisiteit en oorlewing mag maniere verskaf om by díe sekresie sisteme in te meng, wat 
moontlik kan lei tot ontwikkelings in die voorkoming en behandeling van tuberkulose. 
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INTRODUCTION 
 
The Mycobacterium tuberculosis ESX-3 secretion system interactome 
 
Mycobacterium tuberculosis is the causative agent of tuberculosis, causing almost 10 million new 
cases of disease and resulting in approximately 1.7 million deaths each year (World Health 
Organisation, 2009). Despite the availability of anti-tuberculosis drugs and the BCG vaccine, the 
tuberculosis prevalence continues to increase (World Health Organisation, 2009). Although 
tuberculosis disease has been extensively researched, little is understood of the mechanisms of 
pathogenicity of the organism. Understanding these virulence mechanisms may lead to novel 
developments in the treatment and prevention of tuberculosis disease.  
Comparative genomic analyses have identified a single region of the M. tuberculosis genome, named 
RD1, which is absent from all strains of the attenuated vaccine strain, M. bovis BCG (Mahairas et al., 
1996; Behr et al., 1999). Deletion of RD1 has been shown to attenuate M. tuberculosis (Guinn et al., 
2004; Hsu et al., 2003; Lewis et al., 2003). RD1 contains nine M. tuberculosis genes which form part 
of the larger ESAT-6 gene cluster region 1. There are 5 copies of the ESAT-6 gene cluster in the M. 
tuberculosis genome, named regions 1 to 5, each encoding potent exported T-cell antigens (ESAT-6 
and CFP-10), serine proteases, ATP-binding proteins and other membrane associated proteins 
(Tekaia et al., 1999; Gey van Pittius et al., 2001). Each of these ESAT-6 gene clusters encodes a 
dedicated protein secretion system, called ESX-1, 2, 3, 4 and 5 (Abdallah et al., 2007; Simeone et al., 
2009).  
These secretion systems are responsible for the secretion of proteins, including the T-cell antigens, 
ESAT-6 and CFP-10 across the mycobacterial mycomembrane (Abdallah et al., 2007). Although it is 
known that these secretion systems are involved in virulence and phagosomal escape of M. 
tuberculosis, and that deletion of some of these regions causes attenuation of the organism, the 
structure, substrates and functions of the systems are largely unknown.  
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The ESAT-6 gene cluster region 3, encoding the ESX-3 secretion system, is the only ESAT-6 gene 
cluster that is essential for growth in M. tuberculosis  (Sassetti et al., 2003). It is, however, not 
essential in the fast-growing saprophyte, M. smegmatis. Expression of ESX-3 is regulated by iron and 
zinc availability as part of the IdeR and Fur/Zur regulons and may be involved in divalent cation 
homeostasis ( Rodriguez et al., 2002; Maciag et al., 2007).   
This study investigates ESX-3 by identifying protein-protein interactions between the ESX-3 
components, in order to create a model of the ESX-3 secretion system interactome. In addition, a 
ESX-3 knockout strain of M. smegmatis was constructed in this study. This will enable future studies to 
investigate the functions of ESX-3, which may help to establish the essential nature of this secretion 
system in M. tuberculosis. In this study the M. smegmatis ESX-3 knockout was used to investigate the 
functional conservation of ESX-3 in M. tuberculosis and M. smegmatis by establishing whether M. 
smegmatis ESX-3 is able to secrete the M. tuberculosis ESX-3 protein EsxH (TB10.4). 
This study assists in elucidating the structure of the ESX-3 secretion systems, which serves as a 
model for the structure of the other ESX secretion systems, and assists in expanding our knowledge of 
the function of ESX-3. This study lays the foundation for future work on these systems, which may 
provide clues as to how these secretion mechanisms may be interfered with, potentially leading to 
developments in the prevention and treatment of tuberculosis disease. 
 
 PROBLEM STATEMENT 
 
M. tuberculosis is the causative agent of tuberculosis, a disease which continues to spread and kill 
millions of people each year. Although the disease, and M. tuberculosis, has been extensively studied, 
little is understood of the mechanisms of pathogenicity of the organism. The five ESAT-6 gene clusters 
of M. tuberculosis each encode a dedicated secretion system, responsible for the transport of proteins 
from the cell. These secretion systems are essential for the virulence and survival of M. tuberculosis. A 
better understanding of the structure, substrates, mechanism, regulation and functions of these 
secretion systems may lead to novel developments in the treatment and prevention of tuberculosis 
disease.  
 
 AIMS 
 
This study aims to investigate the M. tuberculosis ESX-3 secretion system, specifically  
1. To identify protein-protein interactions within the ESX-3 secretion system. 
2. To create a model of the ESX-3 secretion machinery. 
3. To identify protein-protein interactions between the Esx proteins encoded by the ESX-3 and 
duplicated from it. 
4. To create an ESX-3 knock-out strain of M. smegmatis. 
5. To determine whether the ESX-3 secretion system of M. tuberculosis is functionally conserved 
in M. smegmatis by establishing whether the M. smegmatis ESX-3 is able to secrete the M. 
tuberculosis EsxH protein. 
 
 CHAPTER 1 
 
The Mycobacterium tuberculosis ESX secretion systems 
LITERATURE REVIEW 
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Tuberculosis is an infectious disease caused by the bacterium Mycobacterium tuberculosis (Koch, 
1882). Approximately two-thirds of the world’s population is infected with M. tuberculosis, with 
approximately 10 million new cases of active tuberculosis, resulting in 1.75 million deaths, each year 
(World Health Organisation, 2009). Despite the availability of anti-tuberculosis drugs and the BCG 
vaccine, the prevalence of tuberculosis disease continues to increase. The ineffectiveness of the BCG 
vaccine against adult tuberculosis, the high prevalence of HIV in areas with high tuberculosis burden, 
and the development of drug resistance, especially MDR (multidrug resistant) and XDR (extensively 
drug resistant) tuberculosis, contribute to the increasing tuberculosis prevalence (World Health 
Organisation, 2007; 2008). In order to combat this disease, new, more effective vaccines and drugs 
need to be developed. Despite extensive research into tuberculosis and M. tuberculosis, very little is 
understood about the mechanisms of pathogenicity of the organism. A better understanding of this 
pathogen and its virulence mechanisms may lead to novel developments in the treatment and 
prevention of tuberculosis disease.  
Mycobacteria 
M. tuberculosis is a member of the genus Mycobacterium, which consists of about 147 species and 11 
subspecies, and contains both pathogenic and non-pathogenic saprophytic bacteria (Euzeby, 2009). 
The Mycobacteria are non-motile, non-sporulated, acid-fast, rod-shaped bacteria characterized by the 
high GC (guanine and cytosine) content of their genomes and their lipid-rich cell walls containing 
mycolic acids (Shinnick and Good, 1994). Mycobacteria are classified as fast-growing if they form a 
colony on solid growth medium within 7 days, and as slow-growing if they only form visible colonies 
after 7 days (Shinnick and Good, 1994). An example of a fast-growing mycobacterium is M. 
smegmatis, which forms a colony in about 3 days. M. tuberculosis is a slow-growing mycobacterium 
which only forms a colony after 3 to 4 weeks. Most fast-growing mycobacteria are saprophytic, while 
the majority of pathogenic mycobacteria are slow-growers.   
The M. tuberculosis complex, comprising the closely related species M. africanum, M. bovis, M. 
canetti, M. caprae, M. microti, M. pinnipedii, M. tuberculosis, the oryx bacillus and the dassie bacillus, 
causes tuberculosis disease in humans and animals (Brosch et al., 2000b). The attenuated M. bovis 
BCG strain, also a member of the complex, was developed after serial passaging of a virulent M. bovis 
strain by Calmette and Guérin between 1908 and 1919 and is used to vaccinate children to prevent 
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tuberculosis disease (World Health Organisation, 2004). Other pathogenic mycobacteria include M. 
leprae and M. ulcerans which cause Leprosy and Buruli Ulcer respectively (MacCallum et al., 1948; 
Gelber, 1994). Some mycobacteria such as M. smegmatis occur in the environment as saprophytes, 
while others infect a variety of non-human hosts.  
The ESAT-6 gene cluster 
The whole genome sequence of the laboratory strain M. tuberculosis H37Rv was described by Cole et 
al (1998). This, together with the use of other comparative genomic techniques, allowed for the 
identification of various Regions of Difference (RDs) between closely related virulent and non-virulent 
strains and species (Mahairas et al., 1996; Philipp et al., 1996; Brosch et al., 1998, 1999, 2000a; 
Gordon et al., 1999a; Behr et al., 1999). These analyses identified a single region of the M. 
tuberculosis and M. bovis genomes, named RD1, which is absent from all substrains of the vaccine 
strain M. bovis BCG (Mahairas et al., 1996; Behr et al., 1999). This is believed to be the principal 
deletion which resulted in the attenuation of M. bovis BCG (Behr et al., 1999; Brosch et al., 2000a). 
This region is present in the genomes of M. bovis and M. africanum, both virulent members of the M. 
tuberculosis complex, but is absent in M. microti, which seldom causes disease in immuno-competent 
individuals (Van Soolingen et al., 1998, Gordon et al., 1999a; Brodin et al., 2002). Deletion of RD1 has 
been shown to cause attenuation of M. tuberculosis (Hsu et al., 2003; Lewis et al., 2003; Guinn et al., 
2004), leading to the hypothesis that the RD1 region contains elements which contribute to 
mycobacterial pathogenicity.  
RD1 is a 9505bp region containing nine M. tuberculosis genes, Rv3871 to Rv3879c. Included in this 
region are genes encoding the 6 kDa early secreted antigenic target (ESAT-6, Rv3875) and culture 
filtrate protein 10 (CFP-10, Rv3874) (Berthet et al., 1998; Gey van Pittius et al., 2001). ESAT-6 and 
CFP-10 are two potent T-cell antigens which were identified from the short term culture filtrates of M. 
tuberculosis (Andersen et al., 1995). Although these proteins contain no known signal sequences 
(Sorensen et al., 1995; van Pinxteren et al., 2000), their secretion is essential for M. tuberculosis 
virulence (Hsu et al., 2003; Lewis et al., 2003; Stanley et al., 2003; Guinn et al., 2004).  
Further analysis identified a cluster of genes surrounding and including the ESAT-6 and CFP-10 
genes, of which there are 5 copies in the M. tuberculosis genome (Tekaia et al., 1999). These 5 gene 
clusters have been named the ESAT-6 gene cluster regions 1 (Rv3866-Rv3883c, encompassing 
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RD1), 2 (Rv3884c-Rv3895c), 3 (Rv0282-Rv0292), 4 (Rv3444c-Rv3450c) and 5 (Rv1782-1798) and 
phylogenetic analyses indicate that they were duplicated from the ancestral region, Region 4, in the 
order 3, 1, 2 and then 5 (Figure 1.1, Gey van Pittius NC, personal communication). Twelve gene 
families are represented within the 5 gene cluster regions and were designated families A to L 
according to their position in Region 1 (Gey van Pittius et al., 2001). Six of these gene families are 
present in all 5 regions, and encode the ESAT-6 and CFP-10 homologs as well as a transmembrane 
ATPase, a transmembrane ATP-binding protein, a subtilisin-like membrane-anchored cell wall-
associated serine protease (mycosin) and a putative integral membrane pore protein  (Tekaia et al., 
1999; Gey van Pittius et al., 2001). In addition to the conserved components of the ESAT-6 gene 
clusters, regions 3, 1, 5 and 2 also contain genes encoding several other proteins including PE and 
PPE proteins. Other region-specific genes also occur in some of these clusters (Gey van Pittius et al., 
2001). The presence and positions of the Family A to L genes in each of the 5 ESAT-6 gene cluster 
regions of M. tuberculosis are given in Table 1.1 and the proteins they encode are described below. 
A systematic genetic nomenclature has been proposed for the components of these gene cluster 
regions, and Type VII secretion systems (T7SSs) in general (Bitter et al., 2009). The newly proposed 
terminology is given alongside the old terms in Table 1.1 and in Figure 1.1, however previous 
terminology will be used throughout this thesis.   
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Figure 1.1. The ESAT-6 gene clusters of M. tuberculosis.  The M. tuberculosis ESAT-6 gene clusters evolved in the order 4, 3, 1, 2 and then 5, through 
duplication events and the incorporation of additional genes. The genes of the ESAT-6 gene cluster region 4 are maintained through all the duplications and the 
PE/PPE genes, incorporated into Region 3, in the subsequent duplications. Adapted from Gey van Pittius et al. (2001) 
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Table 1.1. The components of the five ESAT-6 gene clusters of M. tuberculosis.  
Presence of genes in the ESAT-6 gene cluster regions  Gene 
family 
 Description 
1 2 3 4 5 
A ABC transporter family signature Rv3866 (espG1) Rv3889c (espG2) Rv0289 (espG3)  Rv1794  
B AAA+ class ATPases, CBXX/CFQX family, SpoVK, 1x 
ATP/GTP-binding site 
Rv3868 (eccA1) Rv3884c (eccA2) Rv0282 (eccA3)  Rv1798 (eccA5) 
C Amino terminal transmembrane protein, possible ATP/GTP-
binding motif 
Rv3869 (eccB1) Rv3895c (eccB2) Rv0283 (eccB3) Rv3450c (eccB4) Rv1782 (eccB5) 
D DNA segregation ATPase, ftsK chromosome partitioning 
protein, SpoIIIE, YukA, 3x ATP/GTP-binding sites, 2x 
amino-terminal transmembrane protein 
Rv3870 (eccCa1) 
-Rv3871 (eccCb1) 
 
Rv3894c (eccC2) Rv0284 (eccC3) Rv3447c (eccC4) Rv1783 (eccCa5) 
-Rv1784 (eccCb5) 
E PE Rv3872 (pe35) Rv3893c (pe36) Rv0285 (pe5)  Rv1788 (pe18) 
Rv1791 (pe19) 
F PPE Rv3873 (ppe68) Rv3892c (ppe69) Rv0286 (ppe4)  Rv1787 (ppe25) 
Rv1789 (ppe26) 
Rv1790 (ppe27) 
G CFP-10, Esx family protein Rv3874 (esxB) Rv3891c (esxD) Rv0287 (esxG) Rv3445c (esxU) Rv1792 (esxM) 
H ESAT-6, Esx family protein Rv3875 (esxA) Rv3890c (esxC) Rv0288 (esxH) Rv3444c (esxT) Rv1793 (esxN) 
I ATPases involved in chromosome partitioning, 1x 
ATP/GTP-binding motif 
Rv3876 (espI) Rv3888c     
J Integral inner membrane protein, binding-protein-dependent 
transport systems inner membrane component signature, 
putative transporter protein 
Rv3877 (eccD1) Rv3887c (eccD2) Rv0290 (eccD3) Rv3448 (eccD4) Rv1795 (eccD5) 
K Mycosin, subtilisin-like cell wall-associated serine protease Rv3883c (mycP1) Rv3886c (mycP2) Rv0291 (mycP3) Rv3449 (mycP4) Rv1796 (mycP5) 
L 2x amino-terminal transmembrane protein Rv3882c (eccE1) Rv3885c (eccE2) Rv0292 (eccE3)   Rv1797 (eccE5) 
The systematic genetic nomenclature for T7SSs (Bitter et al., 2009) is given in brackets. ecc: esx conserved component; esp: ESX-1 secretion-associated 
protein; mycP: mycosin protease. 
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Esx family proteins – Family G (CFP-10) and Family H (ESAT-6) 
ESAT-6 and CFP-10 were first identified by studies which aimed to identify immunogens which could 
be used to develop new, more effective anti-tuberculosis vaccines. M. tuberculosis culture filtrate 
proteins (CFPs) were purified and tested to determine their antigenicity (Andersen et al., 1995). ESAT-
6 and CFP-10 were highlighted by these studies due to their potent antigenicity (Sorensen et al., 1995; 
Berthet et al., 1998). 
Investigation of the M. tuberculosis whole genome sequence identified 23 genes, including those 
encoding ESAT-6 and CFP-10, which encode a family of related proteins, the Esx proteins (Cole et al., 
1998; Tekaia et al., 1999). These genes were named esxA-esxW, with their respective proteins EsxA-
EsxW. Related proteins have also been identified in actinobacteria and other low GC Gram-positive 
bacteria (Gey van Pittius et al., 2001; Pallen, 2002). They are small proteins of approximately 100 
amino acids, which although not highly conserved in sequence, each contain a WXG amino acid motif 
(Cole et al., 1998; Pallen, 2002). They form a characteristic helix-turn-helix structure (Figure 1.2), the 
hairpin bend formed by the WXG motif (Pallen, 2002; Renshaw et al., 2005). ESAT-6 and CFP-10 are 
encoded by esxA and esxB, and also named EsxA and EsxB, respectively. esxA and esxB are located 
directly adjacent to one another in the M. tuberculosis genome and are cotranscribed (Berthet et al., 
1998).  Twenty-two of the M. tuberculosis esx genes occur in pairs, of which five pairs occur within the 
ESAT-6 gene clusters. The additional six esx gene-pairs, and the individual esx gene, were shown by 
Gey van Pittius et al (2006) to be duplicated from the various ESAT-6 gene clusters. The esx gene 
pairs form operons resulting in the coexpression of the two Esx proteins, which interact to form 
heterodimers (Figure 1.2) which despite the absence of known secretion signals are secreted from the 
cell (Sorensen et al., 1995; van Pinxteren et al., 2000; Pym et al., 2003). Although the Esx proteins 
have been implicated in various functions including virulence, phagosome escape, cytolysis and 
cytotoxicity (Hsu et al., 2003; Gao et al., 2004); their precise functions have not been elucidated. 
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Figure 1.2. The Esx protein complex.  ESAT-6 and CFP-10 interact to form a dimer, with each 
protein consisting of a helix-turn-helix motif and an unstructured C-terminal region. Source: Renshaw 
et al (2005). 
 The PE and PPE proteins – Family E (PE) and Family F (PPE) 
Directly upstream of the esx-esx operons in the ESAT-6 gene cluster regions 1, 2, 3 and 5 is another 
pair of conserved genes, from the PE and PPE gene families. The presence of these genes is also 
conserved in four of the six duplications of the esx-esx operons outside of the ESAT-6 gene clusters, 
suggesting that the 4 genes were duplicated together from the ESAT-6 gene clusters (Gey van Pittius 
et al., 2006). Many additional copies of the PE and PPE genes occur in M. tuberculosis, with the two 
gene families together comprising approximately 10% of the coding material in the M. tuberculosis 
genome (Cole et al., 1998). M. tuberculosis contains 99 PE-encoding genes, which are characterized 
by the proline-glutamic acid (PE) motif at amino acid positions 8 and 9 in a conserved 110 amino acid 
N-terminal domain (Cole et al., 1998; Gordon et al., 1999b; Camus et al., 2002). The PPE proteins, 69 
of which are encoded by M. tuberculosis, have a proline-proline-glutamic acid (PPE) motif at positions 
7 to 9 in a unique conserved N-terminal domain of approximately 180 amino acids (Cole et al., 1998; 
Camus et al., 2002). The N-terminal domains vary significantly between these two protein families, 
which both possess highly variable C-terminal domains (Gordon et al., 1999b). The PE and PPE 
families have been further subdivided into subfamilies based on their C-terminal domains (Figure 1.3). 
The PE family has been divided into two subfamilies. The polymorphic GC-rich-repetitive sequence 
(PGRS) subfamily consists of 65 proteins with multiple tandem repeats of either glycine-glycine-
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alanine or glycine-glycine-asparagine motifs in the C-terminal domain (Poulet and Cole, 1995; Gordon 
et al., 1999b). The other PE subfamily combines 34 PE proteins with low C-terminal homology 
(Gordon et al., 1999b). The PPEs are subdivided into 4 subfamilies (Gordon et al., 1999b; Adindla and 
Guruprasad, 2003). The PPE-SVP subfamily comprises 24 PPE proteins with a Gly-X-X-Ser-Val-Pro-
X-X-Trp motif between amino acids 300 and 350 (Adindla and Guruprasad, 2003). The PPE-MPTR 
subfamily of 23 members contains multiple tandem repeats of a Asp-X-Gly-X-Gly-Asn-X-Gly motif 
(Hermans et al., 1992; Cole et al., 1998). The third subfamily, the PPE-PPW subfamily, contains a 
conserved 44 amino acid region consisting of Phe-X-Gly-Thr and Pro-X-X-Pro-X-X-Trp motifs (Adindla 
and Guruprasad, 2003), while the fourth subfamily contains PPE proteins of low C-terminal homology 
(Gordon et al., 1999b).  
 
 
Figure 1.3. PE and PPE protein structure. Diagrammatic representation of the PE (A) and PPE (B) 
protein subfamilies of M. tuberculosis, showing the conserved N-terminal domains and the variable C-
terminal sequences classifying the proteins into the various subfamilies. Adapted from Gey van Pittius 
et al (2006). 
The large number of PE and PPE proteins encoded by M. tuberculosis suggests that these proteins 
must play an important role in the organism. However the functions of these protein families have yet 
to be elucidated. Studies have suggested that some PPE proteins may be cell wall-associated and 
that some are partially exposed on the cell surface of the organism (Doran et al., 1992; Sampson et 
PE 
PE PGRS – (GGAGGA)n 
Unique sequence 
PPE MPTR – (NxGxGNxG)n 
PPE PPW – (PxxPxxW) 
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al., 2001; Okkels et al., 2003; Le et al., 2005). Various PE-PGRS proteins have been shown to be cell 
surface constituents which influence colony morphology, cellular architecture and are involved in cell-
cell interactions (Brennan et al., 2001; Banu et al., 2002; Delogu et al., 2004). Outer membrane 
anchoring domains have been identified in 40 PE and PPE proteins which may have the potential to 
form β-barrel outer membrane protein structures (Pajon et al., 2006) and PE35 (from the ESAT-6 gene 
cluster region 1) is secreted by M. tuberculosis (Fortune et al., 2005). The high degree of C-terminal 
variation in these protein families suggests that they may play a role in antigenic variation or in the 
inhibition of antigen processing (Cole et al., 1998; Cole, 1999; Gordon et al., 1999b). Alternative 
functions have been suggested for some PE and PPE proteins, including PPE37, expression of which 
is upregulated under iron-poor conditions and which has been proposed to be a siderophore-type 
protein (Rodriguez et al., 1999; Rodriguez et al., 2002). The PE-PGRS Wag22 has been annotated as 
a fibronectin-binding protein (Abou-Zeid et al., 1991; Espitia et al., 1999).  Various PE and PPE 
proteins have also been implicated in phagosome-lysosome fusion, macrophage vacuole acidification, 
granuloma persistence, replication in macrophages and virulence and some have been shown to be 
essential for in vitro or in vivo growth (Sassetti et al., 2003; Li et al., 2005). 
The presence of these proteins in the cell membrane, cell wall and culture filtrates of mycobacteria, 
and the various functions in which they have been implicated requires targeting of the proteins to the 
membrane and/or their secretion from the cell. However, akin to the Esx proteins, no known secretion 
signals have been identified in these proteins. PPE41 and PE25, encoded by Rv2430c and Rv2431c, 
are cotranscribed and interact to form a 1:1 complex (Tundup et al., 2006; Strong et al., 2006) and 
several other PE-PPE protein pairs have also been predicted to form complexes (Strong et al., 2006; 
Riley et al., 2008). PPE68 (encoded from the ESAT-6 gene cluster region 1) has in addition been 
shown to interact with the Esx proteins EsxA, B and H (Okkels and Andersen, 2004). The physical 
association of the ancestral PE and PPE genes with the Esx genes, the analogy of their expression, 
the interactions between them and their proposed involvement in virulence and pathogenesis, suggest 
that the functions of the Esx and PE and PPE proteins may be linked. 
 The mycosins – Family K  
Each of the ESAT-6 gene clusters encodes a subtilisin-like cell wall-associated serine protease (Cole 
et al., 1998; Gey van Pittius et al., 2001). These proteases are named mycosin-1, -2, -3, -4 and -5 
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according to the numbering adopted for the ESAT-6 gene clusters, encoded by mycP1 to mycP5 
(Brown et al., 2000).  The mycosins contain several features of serine proteases of other bacteria. The 
presence of the catalytic triad, consisting of an aparagine, histidine and serine residue, together with 
specific active site signatures classified these proteases as subtilisin-like proteases. Other features of 
these proteases include their hydrophobic N-termini which are likely signal peptides, cleaved at a 
conserved sequence position following an Ala-X-Ala motif. The C-terminal domains consist of 
hydrophobic stretches interspersed with charged residues indicative of transmembrane domains and a 
proline-rich linker connects the transmembrane and catalytic domains. The structure of the mycosins 
is described in Figure 1.4. The mycosins are located in the cell wall and cell membrane of 
mycobacteria and may be involved in processing of extracellular or secreted proteins, and in this way 
contribute to virulence of mycobacteria (Brown et al., 2000). Mycosin-1 has been shown to be 
expressed following the infection of macrophages, supporting the role of these proteases in 
mycobacterial pathogenicity (Dave et al., 2002). The substrates and specific functions of the mycosins 
have not yet been determined. 
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Figure 1.4. The structure of the mycosins. The predicted domains (A) and proposed structure (B) of 
the mycosin proteases. The mycosin proteases each contain an N-terminal signal peptide, a pro-
peptide, a subtilase domain containing the catalytic triad (D-H-S)*, a proline-rich linker and a C-
terminal transmembrane domain. The signal sequence targets the mycosin for secretion and is 
cleaved at an A-I cleavage site. The pro-peptide is cleaved at a putative Q-R pro-peptide cleavage 
site, resulting in activation of the subtilisin protease domain. The transmembrane domain anchors the 
mycosin in the cell membrane. IM: inner membrane; MM: mycomembrane. 
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ATPases – Families B, D and I 
The ESAT-6 gene clusters each contain at least one, and up to three ATPase genes. ATPases are 
enzymes which convert chemical energy, in the form of ATP, to biological activity through the 
dephosphorylation of ATP to ADP. The ATPases are encoded by gene families B, D and I.  
The Family B ATPase has been described as an AAA+ class ATPase of the CBXX/CFQX family 
containing one ATP/GTP-binding site (Tekaia et al., 1999). AAA+ ATPases have been shown to be 
essential for the assembly of the bacterial Type VI secretion system machinery (Bonemann et. al., 
2009). A Family B ATPase is encoded by each of the ESAT-6 gene clusters duplicated from region 4, 
but not by region 4 (Gey van Pittius et al., 2001). Rv3868, encoded by region 1, is approximately 63 
kDa in size, and assembles as a hexamer (Ogura et al., 2004; Luthra et al., 2008). Each peptide 
consists of 2 domains, the C-terminal ATPase and oligomerisation domain and the helical N-terminal 
domain which is involved in the regulation of C-terminal ATPase activity (Figure 1.5). ATP binding to 
the protein and subsequent hydrolysis results in “open-close” movements of the protein domains, 
predicted to allow interactions with, and energy transfer to other proteins (Luthra et al., 2008).  
Figure 1.5. The structure of the Family B ATPase. A. The family B ATPases contain an ATPase 
domain of the CBXX/CFQX family in the C-terminal of the protein. B. The ATPase hexamerises. The 
proteins interact via the C-terminal region (in purple), which also contains the ATPase domain 
(blocked). ATP hydrolyses results in movements of the N-terminal region (in brown), as represented 
by the arrows. Source: Luthra et al. (2008). 
         100      200       300       400      500 
ATPase 
A B 
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The Family D ATPase is described as a DNA segregation ATPase and ftsK chromosome partitioning 
protein of the FtsK/SpoIIIE family and contains three ATP/GTP-binding motifs and two N-terminal 
transmembrane domains (Figure 1.6). Proteins of this family are essential for the functioning of Type 
IV secretion systems where they function as coupling proteins (Christie et al., 2005). In Regions 1 and 
5, the gene encoding this ATPase has been split in two resulting in the expression of a 
transmembrane protein containing a single ATPase domain and a cytoplasmic protein with two 
ATPase domains (Tekaia et al., 1999; Gey van Pittius et al., 2001).  
 
 
Figure 1.6. The structure of the Family D ATPase. The Family D ATPases contain 3 P-loop ATPase 
domains and a FtsK motif and are anchored in the membrane via 2 N-terminal transmembrane 
domains.  
The Family I ATPase, which shows homology with ATPases involved in chromosome partitioning, is 
only encoded by the ESAT-6 gene cluster regions 1 and 2. This ATPase is proline and alanine rich, 
contains an ATP/GTP binding motif and may be membrane bound (Gey van Pittius et al., 2001). 
  Integral membrane protein – Family J 
The Family J proteins, encoded by all five ESAT-6 gene cluster regions, are predicted to consist of 
eleven or twelve transmembrane helices which form a pore through the lipid bilayer.  This protein is a 
putative transporter protein as it contains the signature of the inner membrane-component of binding 
protein-dependent transport systems (Tekaia et al., 1999; Gey van Pittius et al., 2001). 
 ABC transporter – Family A 
The Family A genes present in the ESAT-6 gene cluster regions 1, 3, 2 and 5 encode proteins of 
approximately 500 amino acids which contain a hydrophobic region in the N-terminal domain (Tekaia 
et al., 1999; Gey van Pittius et al., 2001). An ABC (ATP binding cassette) signature has been 
identified in this protein and homology has been found with DNA binding proteins (Gey van Pittius et 
al., 2001; Tuberculist). 
FtsK ATPase ATPase ATPase 
transmembrane domains 
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 Amino-terminal membrane proteins – Families C and L 
Two additional membrane proteins are encoded by the ESAT-6 gene clusters. The Family C amino-
terminal transmembrane protein is encoded by all five ESAT-6 gene clusters and a possible ATP/GTP 
binding motif has been identified. The Family L proteins contain two amino-terminal transmembrane 
motifs and is encoded in regions 1, 3, 2 and 5 (Gey van Pittius et al., 2001). Little else is known about 
these protein families. 
The ESX secretion systems 
Mycobacteria have a complex cell wall structure due to the presence of mycolic acids (large, 
hydroxylated branched-chain fatty acids) which are covalently linked to the cell wall to form an 
additional hydrophobic layer called the mycomembrane (Bayan et al., 2003). The mycomembrane not 
only forms a barrier to the influx of hydrophilic substances, but also restricts the secretion of 
hydrophilic molecules, including extracellular proteins, from the cell. Therefore the secretion of 
extracellular proteins, including Esx, PE and PPE, likely requires an active secretion system. These 
proteins do not contain any known secretion signals and therefore do not appear to be secreted 
through the general secretion machinery (Sec) or other previously identified secretion mechanisms 
(Sorensen et al., 1995; van Pinxteren et al., 2000). It is proposed that the proteins encoded by each 
ESAT-6 secretion system form a dedicated secretion system responsible for the secretion of the Esx, 
PE and PPE proteins and other substrates across the mycomembrane. These secretion systems were 
named the ESAT-6 secretion systems 1 to 5 (ESX-1 to 5) and have been classified as a novel type of 
secretion system, Type-VII secretion system (Abdallah et al., 2007). Several ESAT-6 gene cluster 
region 1 proteins have been shown to be essential for the secretion of ESAT-6 and CFP-10 affirming 
the hypothesis that these gene clusters encode secretion machinery (Brodin et al., 2006). Each ESX 
secretion system is predicted to be responsible for the secretion of the Esx proteins encoded by its 
ESAT-6 gene cluster, and may in addition secrete the associated PE and PPE proteins as well as 
other unassociated proteins. Figure 1.7 describes the basic secretion mechanism of the ESX secretion 
systems. Each of the M. tuberculosis ESX secretion systems is described below. 
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Figure 1.7. The basic Type-VII ESX secretion machinery. It is proposed that the Esx proteins 
(Family G and H) from each ESAT-6 gene cluster interact to form a complex which interacts with the 
FtsK/SpoIIE (Family D) transmembrane ATPase to provide the energy for translocation of the protein 
complex through a membrane pore protein, likely the Family J integral membrane protein. The 
functions of the other components of the ESAT-6 gene clusters remain unknown. In addition the 
mycomembrane channel component remains unidentified.  
ESX-1 
Due to its direct involvement in the virulence of M. tuberculosis, ESX-1 has been extensively 
researched and is the best characterized ESX secretion system. The involvement of the ESAT-6 gene 
cluster region 1 in secretion was recognized when it was noted that several genes surrounding esxA 
and esxB are essential for ESAT-6 and CFP-10 secretion (Hsu et al., 2003; Pym et al., 2003; Stanley 
et al., 2003; Gao et al., 2004; Guinn et al., 2004). Thus it was deduced that the RD1 region, and as 
such the ESAT-6 gene cluster region 1, is involved in ESAT-6 secretion. 
 In addition to ESAT-6 and CFP-10, the M. tuberculosis ESX-1 secretion system also secretes PE35, 
PPE68 and EspB (Rv3881c, ESX-1 secretion-associated protein B), EspF (Rv3865, ESX-1 secretion-
associated protein F, encoded directly upstream of the ESAT-6 gene cluster region 1) and three 
genetically unlinked proteins, EspA (Rv3616c, ESX-1 secretion-associated protein A), EspC 
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(Rv3615c, ESX-1 secretion-associated protein C) and EspR (Rv3849, ESX-1 secretion-associated 
protein R) (Fortune et al., 2005; McLaughlin et al., 2007; Xu et al., 2007; Raghavan et al., 2008; 
Giuseppe Champion et al., 2009). ESAT-6 and CFP-10 are coexpressed in an operon and interact to 
form a heterodimer which is secreted from the cell (Berthet et al., 1998). The genes encoding EspA 
and EspC are also part of an operon with Rv3614c. Interestingly EspA, EspC and Rv3614c show 
significant homology to Rv3864, EspF and Rv3867, which are located directly upstream of the ESAT-6 
gene cluster region 1 (Fortune et al., 2005) and EspC and EspF have been shown to interact 
(Giuseppe Champion et al., 2009).  EspR is a transcriptional regulator which activates transcription 
from the Rv3616c-Rv3614c promoter ensuring proper functioning of the ESX-1 secretion machinery. 
EspR is also secreted by ESX-1, suggesting that ESX-1 activity is regulated by a direct negative 
feedback system (Raghavan et al., 2008). EspB is an additional ESX-1 substrate, which is encoded by 
the ESAT-6 gene cluster region 1 (McLaughlin et al., 2007). All these ESX-1 substrate proteins appear 
to be dependant on each other for secretion, despite variations in the specific ESX-1 components 
required for their individual secretion (Fortune et al., 2005; McLaughlin et al., 2007; Xu et al., 2007; 
Raghavan et al., 2008). It is suggested that these proteins may interact prior to, or during the secretion 
process and that these interactions are essential for proper ESX-1 functioning. Alternatively, these 
proteins may not be substrates but rather components of the ESX-1 secretion machinery, which are 
incidentally secreted (Fortune et al., 2005; Ize and Palmer, 2006). The secretion of all these ESX-1 
substrates is required for full virulence of M. tuberculosis.   
Brodin et al (2006) classified the gene components of the ESAT-6 gene cluster region 1 into four 
groups according to their roles in ESAT-6 secretion. (1) Genes required for the presence of ESAT-6 
and CFP-10 in the whole cell lysate; esxA, esxB and Rv3872 (encoding PE35).  (2) Genes required for 
the secretion of ESAT-6 and CFP-10 from the cell; Rv3877, Rv3871, Rv3870, Rv3868 and Rv3869. 
(3) Genes which do not affect ESAT-6 and CFP-10 secretion or ESAT-6 specific immunogenicity but 
inactivation of which leads to enhanced virulence; Rv3864, Rv3867, Rv3873 (encoding PPE68), 
Rv3876, Rv3878 and Rv3879. (4) Genes which do not affect ESAT-6/CFP-10 secretion, but deletion 
of which causes attenuation; Rv3865, Rv3866. 
The roles of some of the proteins required for ESAT-6/CFP-10 secretion have been previously 
described; Rv3868 and Rv3871 are ATPases which presumably provide the energy for transport of 
the substrates across the cell membrane. The ESAT-6/CFP-10 complex binds to Rv3871 (Renshaw et 
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al., 2002; Hsu et al., 2003; Stanley et al., 2003; Guinn et al., 2004; Renshaw et al., 2005; Champion et 
al., 2006), and EspC has been shown to bind to Rv3868 (Giuseppe Champion et al., 2009). Therefore 
it appears that these proteins are responsible for providing the energy for secretion of specific 
substrates. Rv3868 may also act as a chaperone, assisting in the formation of the secreted protein 
complex. Rv3870, which is membrane associated, binds to Rv3871, anchoring it to the membrane and 
may facilitate the functioning of Rv3871 (Stanley et al., 2003). Rv3869 is another membrane protein of 
unknown function, which likely forms part of the secretion machinery. Rv3877 has 11 transmembrane 
helices and is believed to form the membrane pore through which the substrates are transported 
(Tekaia et al., 1999; Gey van Pittius et al., 2001). It is suggested that PPE68 (encoded by Rv3873), 
may be a gating protein, controlling the secretion of ESAT-6, thereby explaining the increase in ESAT-
6 secretion in Rv3873 deletion mutants (Brodin et al., 2006). Protein interactions between PPE68 and 
ESAT-6, CFP-10, Rv3868, Rv3866 and itself have been identified (Okkels and Andersen, 2004; 
Teutschbein et al., 2009). PPE68 may interact with the secretion machinery and the ESAT-6/CFP-10 
complex to prevent ESX-1 secretion. Interestingly PE35, which appears to be required for the 
expression of ESAT-6 and CFP-10 is also secreted by M. tuberculosis (Fortune et al., 2005). The M. 
tuberculosis ESX-1 secretion machinery is described in Figure 1.8.  
ESX-1 in M. tuberculosis appears to be involved in cytolysis, haemolysis, cytotoxicity to macrophages, 
bacterial spreading and macrophage escape, leading to its role in virulence (Hsu et al., 2003; Gao et 
al., 2004; van der Wel et al., 2007). Interestingly, the non-pathogenic M. smegmatis contains a 
functionally equivalent ESX-1, which is able to secrete M. tuberculosis ESAT-6 and CFP-10 (Converse 
and Cox, 2005). M. smegmatis ESX-1 is involved in conjugal DNA transfer, and the M. tuberculosis 
ESX-1 is able to complement the conjugation phenotype of M. smegmatis ESX-1 mutants (Flint et al., 
2004; Coros et al., 2008). This suggests that the function of ESX-1 is conserved between the two 
species, although conjugative DNA transfer has not been observed in M. tuberculosis, and ESX-1 
does not confer virulence to M. smegmatis. The significance of these observations remains to be 
established.  
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Figure 1.8. The ESX-1 secretion machinery.  Various studies have resulted in a model of ESX-1 
secretion. ESAT-6 and CFP-10, and EspF and EspC form complexes which interact with each other. 
CFP-10 and EspC interact with the ATPases Rv3871 and Rv3868 respectively, which provide energy 
for translocation of the protein complex through the membrane pore, Rv3877. Rv3871 is associated 
with the membrane via its interaction with Rv3870. EspB interacts with Rv3879c, which may in turn 
interact with Rv3871 resulting in its secretion. EspA may be associated with the secreted protein 
complex via Rv3868. All these substrates are dependant on one another for secretion. PPE68 may be 
a gating protein regulating the secretion of the ESX-1 substrates. PE35 and EspR are also secreted 
by this secretion machinery via an unknown mechanism. PPE68 and PE35 also interact to form a 
protein complex, this complex may separate after secretion, releasing PE35, while PPE68 obstructs 
the pore. The protein responsible for the transport of the substrates through the MM remains 
unknown.  IM is the inner membrane, MM is the mycomembrane.   
ESX-2 
The ESX-2 secretion system of M. tuberculosis is encoded by the genomic region Rv3895c to 
Rv3884c, located directly adjacent to the ESAT-6 gene cluster region 1 (Gey van Pittius et al., 2001). 
This secretion system has not been investigated and its function(s) remain unknown. 
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ESX-3 
The ESX-3 secretion system is the only ESX system which is essential for in vitro growth of M. 
tuberculosis (Sassetti et al., 2003), although ESX-3 is not required for the growth of M. smegmatis. 
Expression of ESX-3 is regulated by divalent cation levels, particularly iron and zinc, as part of the 
IdeR and Fur/Zur regulons (Rodriguez et al., 2002; Maciag et al., 2007; Siegrist et al., 2009). Recently 
Serafini et al (2009) have constructed an M. tuberculosis ESX-3 conditional mutant in which ESX-3 
transcription can be downregulated. They showed that ESX-3 is essential for M. tuberculosis survival, 
but that the mutant can be complemented by high concentrations of iron, zinc or wild-type culture 
supernatant (Serafini et al., 2009). This confirms the role of ESX-3 in iron and zinc homeostasis and 
suggests that this region is involved in the uptake of divalent cations, possibly by secreting soluble 
cation-binding proteins. M. leprae is unable to produce any siderophores, but is still able to survive 
and infect, suggesting that it has other mechanisms of iron uptake (Quadri, 2008). As M. leprae 
possesses the ESX-3 secretion system, Serafini et al (2009) suggest that ESX-3 may be responsible 
for iron uptake in this organism. In contrast, Siegrist et al (2009) showed that ESX-3 is required for the 
acquisition of iron from mycobactin, suggesting that M. leprae utilises an alternate mechanism of iron 
acquisition. The ESX-3 of M. smegmatis is also regulated by iron concentration, but not by zinc 
concentration (Maciag et al., 2009). Maciag et al (2009) suggest that that while iron is limiting in both 
the human host and the soil environments; M. smegmatis is unlikely to experience zinc deficiency in its 
natural environment, resulting in this difference in regulation. 
The role of ESX-3 in iron and zinc homeostasis suggests that ESX-3 may be highly expressed during, 
and play an important role in the infective process, during which the host restricts the amount of iron 
available to the pathogen. Siegrist et al (2009) have recently shown that ESX-3 is required for growth 
of M. tuberculosis in macrophages. This would also explain the potent antigenicity of EsxH (TB10.4) 
which has been identified in short-term culture filtrates (Skjot et al., 2000). ESX-3 is involved in metal 
cation uptake, enabling the acquisition of metal ions from mycobactin and possibly zinc transporters. 
The mechanism by which it functions, its structure and its substrates remain unclear. 
ESX-4 
The ESAT-6 gene cluster region 4 is the most ancient ESAT-6 gene cluster, from which the other 
regions were duplicated (Gey van Pittius et al., 2001). It is the smallest of the ESAT-6 gene cluster 
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regions and does not encode any PE or PPE proteins. The ESX-4 secretion system probably performs 
the original functions of the ESX system, although this remains to be investigated.  
Until recently ESX-4 was the only ESX system identified outside of the genus Mycobacteria. ESX-4-
like clusters have been identified in Nocardia farcinica, Gordonia bronchialis, Corynebacterium 
diptheriae and various Rhodococcus species, indicating that this secretion system may be conserved 
amongst the high GC Gram-positive bacteria (N.C. Gey van Pittius, personal communication). 
Recently another ESX cluster was identified in N. farcinica which contains all the conserved 
components of the larger ESX systems (Bitter et al 2009). In addition Esx-like proteins have been 
identified in various other low GC Gram-positive bacteria including Bacillus anthracis and 
Staphylococcus aureus (Pallen, 2002; Burts et al., 2005; Garufi et al., 2008). Although the only 
additional member of the ESX system encoded at these loci is the FtsK/SpoIIIE-like protein, the Esx 
proteins are actively secreted by a mechanism which requires these FtsK/SpoIIE proteins, and 
secretion thereof is important for virulence. 
 The ESX-4 secretion machinery is widely spread amongst high GC Gram-positive bacteria and 
appears to have its roots in a shared ancestor of the low GC Gram-positive bacteria, from which it has 
expanded and evolved into the immunopathologically important ESX secretion systems present in M. 
tuberculosis.   
ESX-5 
The ESAT-6 gene cluster region 5 is the most recent duplication, and is found only in the slow-growing 
mycobacteria (Gey van Pittius et al., 2001). There are 3 copies of the PPE and 2 copies of the PE 
genes in this gene cluster of M. tuberculosis, and it appears that these genes have a greater 
propensity for duplication when associated with this system. Gey van Pittius et al (2006) showed that 
these gene families, especially the PE-PGRS and PPE-MPTR subfamilies, expanded out of the ESX-5 
duplication. The M. marinum ESX-5 secretion system, in addition to secreting the Esx proteins 
encoded in this region, also secretes several PPE and PE_PGRS proteins (Abdallah et al., 2006; 
Abdallah et al., 2009). ESX-5 may be responsible for the secretion of all the PPE-MPTR and PE-
PGRS proteins, which evolved subsequent to the ESX-5 duplication (Gey van Pittius et al., 2006). 
These ESX-5 substrates are either secreted proteins, or cell surface proteins which appear to be 
involved in the modulation of the macrophage response against M. marinum, mediated by the 
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expression of cell surface antigens, a reduction in the cytokine response and induction of cell death 
(Abdallah et al., 2008). Therefore it appears that ESX-5 plays an important role in immune evasion by 
mycobacteria. The absence of ESX-5, and the PPE-MPTR and PE-PGRS proteins, in fast-growing 
mycobacteria, which seldom cause disease, supports this role of ESX-5 in immune evasion. 
Interactions between the ESX secretions systems 
The ESX secretion systems of M. tuberculosis appear to be functionally distinct and proteins encoded 
by one ESAT-6 gene cluster region do not complement homologous proteins knocked out of another 
region. Interestingly, although regulation of expression is different for each of the ESAT-6 gene 
clusters, deleting one ESX secretion system can influence the expression of components of the other 
ESX systems (Abdallah et al., 2006; 2007). Recently, Callahan et al (2009) identified protein 
interactions between EsxA and EsxB (the ESAT-6 and CFP-10 proteins from ESX-1) and Rv3884c 
and Rv3885c, two proteins encoded in region 2. Whether these ESX-2 proteins can complement their 
equivalents in ESX-1, and whether they will interact in the presence of the ESX-1 homologs, is 
unclear. Therefore the nature of the relationship between the different ESX secretion systems remains 
to be determined. 
Conclusion 
There are five ESAT-6 gene cluster regions in M. tuberculosis, each of which encodes a dedicated 
ESX secretion system responsible for the secretion of the associated Esx proteins and other 
substrates. Although some of these secretion systems have been implicated in the virulence of M. 
tuberculosis and ESX-3 is essential for its survival, the specific functions of the secretion systems 
have not been determined. In addition, the virulence-associated ESX-1 secretion system is present in 
some non-pathogenic mycobacteria such as M. smegmatis, suggesting that this region has a function 
besides virulence. ESX-3, though essential in M. tuberculosis, is not essential (and is differentially 
regulated) in M. smegmatis. Although several substrates of the various secretion systems have been 
identified, hinting at possible functions of the systems, the precise and distinct role of each ESX 
secretion system remains undeciphered. In addition, it remains unclear as to how these ESX secretion 
systems interact with one another. Despite extensive research on these virulence-associated ESX 
secretion systems, very little is clearly understood regarding their substrates, structure, mechanism, 
regulation and functions; elucidation of which may lead to developments in the prevention and 
treatment of tuberculosis disease. 
 CHAPTER 2 
 
The Mycobacterium tuberculosis ESX-3 secretion system interactome 
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2.1. Introduction 
The ESAT-6 gene cluster region 3 is the only ESAT-6 gene cluster that is essential for growth in M. 
tuberculosis (Sassetti et al., 2003), but it is not essential in the fast-growing saprophyte, M. 
smegmatis. Expression of ESX-3 is regulated by iron and zinc availability as part of the IdeR and 
Fur/Zur regulons (Rodriguez et al., 2002; Maciag et al., 2007), and may be involved in divalent cation 
homeostasis. Recently Serafini et al (2009) have constructed a conditional ESX-3 knockout of M. 
tuberculosis, in which down regulation of ESX-3 expression is lethal to the organism, but may be 
complemented by iron, zinc or wild-type culture filtrate (Serafini et al., 2009). It is clear that the ESX-3 
secretion system is involved in metal cation homeostasis, and may be involved in the secretion of 
factors which are involved in the uptake of these, and other, metal cations.  
Three additional Esx proteins, EsxQ (Rv3017c), EsxR (Rv3019c), and EsxS (Rv3020c), located 
outside of the ESAT-6 gene clusters in the M. tuberculosis genome, were shown to be duplicated from 
the ESAT-6 gene cluster region 3 (Gey van Pittius et al., 2006). The amino acid sequences of EsxG 
and EsxS are 91% identical, while EsxQ and EsxR are 65% and 84% identical to EsxH, respectively. 
These Esx proteins are also secreted by M. tuberculosis, and are regulated by Zur in response to zinc 
concentration (Maciag et al., 2007), although they do not appear to be repressed by IdeR.   
This study aims to elucidate the structure of the ESX-3 secretion system, encoded by the ESAT-6 
gene cluster region 3, by identifying interacting proteins encoded in the gene cluster and to investigate 
interactions between EsxG, H, Q, R and S, the Esx proteins encoded in, and duplicated from, the 
ESAT-6 gene cluster region 3. Elucidating the structure of the ESX-3 secretion system will serve as a 
model for the structure of the ESX secretion systems, advance our understanding of the mechanisms 
of mycobacterial pathogenicity and may assist in providing clues as to how these secretion 
mechanisms may be interfered with, potentially leading to developments in the prevention and 
treatment of tuberculosis disease. 
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2.2. Experimental approach 
This study makes use of a mycobacterial-2-hybrid system called Mycobacterial – Protein Fragment 
Complementation (M-PFC), developed and described by Singh et al. (2006), to identify interacting 
proteins between components of the ESX-3 secretion system. This two-hybrid technique uses a 
heterologous mycobacterial host organism, M. smegmatis, which is fast growing and non-pathogenic, 
and allows for the identification of interacting mycobacterial proteins. M-PFC has the advantage over 
traditional yeast-2-hybrid systems for the identification of mycobacterial interacting proteins in that the 
intracellular environment of M. smegmatis is more similar to that of M. tuberculosis and as such, 
allows for the correct protein expression, folding, modifications and interactions which may not occur 
in an unrelated host.  
The system is based on the functional reconstitution of two murine dihydrofolate reductase (mDHFR) 
domains fused to the proteins of interest, expressed from the M-PFC expression vectors, pUAB300 
and pUAB400, in M. smegmatis. mDHFR reconstitution confers resistance to the antibiotic 
trimethoprim, allowing for the selection of clones containing interacting proteins on media containing 
the antibiotic (Singh et al., 2006).  The M-PFC technique, as used in this study, is outlined in Figure 
2.1. 
The ESAT-6 gene cluster region 3 consists of 11 genes, which were cloned into each of the M-PFC 
expression vectors in a total of 12 fragments, due to size constraints. In addition, the EsxG-EsxH 
operon was also cloned into pUAB300 to allow coexpression of EsxG and EsxH together with each of 
the other ESX-3 proteins. Each combination of vectors was cotransformed into M. smegmatis to allow 
for the detection of interacting protein pairs. EsxQ, EsxR and EsxS were also cloned into each vector 
and cotransformed with EsxG, EsxH and each other to identify interactions between the ESX-3-
associated Esx proteins. 
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Figure 2.1. Identification of interacting proteins of ESX-3 using M-PFC. Each gene from the M. 
tuberculosis ESAT-6 gene cluster region 3 was PCR amplified and cloned in frame into each of the  
M-PFC expression vectors, pUAB300 and pUAB400. Each pair of expression vectors were 
cotransformed into M. smegmatis. The DHFR-ESX-3 fusion proteins were expressed. Should the two 
ESX-3 proteins interact, the DHFR is reconstituted and is able to break down the antibiotic 
trimethoprim, resulting in the growth of colonies on trimethoprim-containing solid medium. If the two 
ESX-3 proteins do not interact, the trimethoprim becomes toxic to the M. smegmatis cells and no 
colonies form on trimethoprim-containing medium. 
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2.3. Materials and Methods 
All standard molecular techniques were performed essentially as described by Sambrook et al. (1989). 
Techniques and reagents are described in detail in Appendix A.  
2.3.1. Bacterial strains 
E. coli strain JM109 was used for standard cloning procedures and E. coli K12 ER2925 (New England 
Biolabs (NEB)) for methylase-sensitive cloning. M. smegmatis mc2155 was used as a heterologous 
mycobacterial host organism for the detection of protein-protein interactions. 
2.3.2.  Growth Media and Culture conditions 
E. coli was cultured in LB with shaking, and on LB agar plates, overnight at 37 °C.  Solid and liquid 
media were supplemented with antibiotics; ampicillin (50 ug/ml, Roche), kanamycin (50 ug/ml, Sigma) 
and hygromycin (100 ug/ml, Invitrogen); as appropriate. 
M. smegmatis was grown in Middlebrook 7H9 media (BD) with shaking, and on BBLTM Seven H11 
Agar Base (BD) plates, at 37 °C for 2-3 days or as otherwise stated. Solid and liquid media were 
supplemented with 0.5% glycerol, 0.5% glucose and 0.2% Tween-80. Kanamycin (25 ug/ml, Sigma), 
hygromycin (50 ug/ml, Invitrogen) and trimethoprim (15-50 ug/ml, Sigma) were added as appropriate.  
2.3.3. PCR primers 
All DNA and protein sequence information was obtained from the M. tuberculosis H37Rv genome 
sequence database (Tuberculist, http://genolist.pasteur.fr/TubercuList/). Primers were designed using 
Primer Premier 5.0 (PREMIER Biosoft International) and obtained from IDT (through Whitehead 
Scientific, www.whitesci.co.za). Primers were designed to amplify all 12 genes and gene fragments 
from ESX-3 such that the resultant PCR products contain ClaI restriction sites on each end, and could 
be cloned in frame into the expression vectors, pUAB300 and pUAB400 (Table 2.1). 
  31 
Table 2.1. PCR primers used for the amplification of the ESX-3 genes for cloning into the M-PFC vectors 
Name of primer Primer sequence (from 5' to 3') Primer  length 
Tm  
[°C] Gene/ gene fragment amplified 
Product length  
(bp) 
      Rv0282 pUAB400 f ATCGATATGGCGGGCGTAGGTGAA   24 62.1 1929 
Rv0282 pUAB300 f ATCGATGATGGCGGGCGTAGGTGAA   25 64.0 1930 
Rv0282 pUAB300/400 r ATCGATCGTGGTCGTGCTGCTGGTT   25 64.4 
Rv0282 in frame for plasmid vectors  
pUAB400 and pUAB300 
 
            
      Rv0283 pUAB400 f ATCGATGCGGGCATGACGAACCA   23 63.3 1663 
Rv0283 pUAB300 f ATCGATTGCGGGCATGACGAACCA   24 63.2 1664 
Rv0283 pUAB300/400 r ATCGATCGGCGACGAGCCTCAAAGA   25 63.7 
Rv0283 in frame for plasmid vectors  
pUAB400 and pUAB300 
 
            
      Rv0284a pUAB400 f ATCGATGTGAGCAGACTGATCTTTG   25 56.9 2036 
Rv0284a pUAB300 f ATCGATGGTGAGCAGACTGATCTTT   25 58.0 2037 
Rv0284a pUAB300/400 r ATCGATGACTCGATGTGGTAGGC   23 58.5 
Rv0284 up to base 2007 in frame for  
plasmid vectors pUAB400 and pUAB300 
 
            
      Rv0284b pUAB400 f ATCGATAGCGTTTCTCGCCAGATC   24 58.7 2030 
Rv0284b pUAB300 f ATCGATCAGCGTTTCTCGCCAGATC   25 60.8 2031 
Rv0284b pUAB300/400 r ATCGATCATGACTGACTCCCCTTCTG   26 59.7 
Rv0284 from base 1973 in frame for  
plasmid vectors pUAB400 and pUAB300 
 
            
      Rv0285 pUAB400 f ATCGATATGACGTTGCGAGTGGTTCCG   27 62.2 324 
Rv0285 pUAB300 f ATCGATCATGACGTTGCGAGTGGTTCC   27 62.4 325 
Rv0285 pUAB300/400 r ATCGATTGCTCAGCCGCCCACGAC   24 65.6 
Rv0285 in frame for plasmid vectors  
pUAB400 and pUAB300 
 
            
      Rv0286 pUAB400 f ATCGATTACGTACGGGGTCGTGG   23 60.5 1592 
Rv0286 pUAB300 f ATCGATCTACGTACGGGGTCGTG   23 60.0 1593 
Rv0286 pUAB300/400 r ATCGATTCGGAATTCGGTTACTTGCT   26 58.5 
Rv0286 in frame for plasmid vectors  
pUAB400 and pUAB300 
 
            
      Rv0287 pUAB400 f ATCGATGTTATGAGCCTTTTGGATGCTCA   29 60.1 300 
Rv0287 pUAB300 f ATCGATTATGAGCCTTTTGGATGCTCA   27 58.4 301 
Rv0287 pUAB300/400 r ATCGATCAGAACCCGGTATAGGTCGACGC   29 64.0 
Rv0287 in frame for plasmid vectors  
pUAB400 and pUAB300 
 
            
      Rv0288 pUAB400 f ATCGATGTGATGTCGCAAATCATGTACA   28 58.6 388 
Rv0288 pUAB300 f ATCGATTGTGATGTCGCAAATCATGTACA   29 58.7 389 
Rv0288 pUAB300/400 r ATCGATCGCCCCAATGGTTTCAGC   24 61.9 
Rv0288 in frame for plasmid vectors  
pUAB400 and pUAB300 
 
            
      Rv0289 pUAB400 f ATCGATATGGATGCAACACCCAACGC   26 61.4 1000 
Rv0289 pUAB300 f ATCGATCATGGATGCAACACCCAACG   26 61.4 1001 
Rv0289 pUAB300/400 r ATCGATCCTGCTGTCCGCAAGAATGG   26 62.7 
Rv0289 in frame for plasmid vectors  
pUAB400 and pUAB300 
 
            
      Rv0290 pUAB400 f ATCGATCCAGGAACGGTCCCGCTGAT   26 65.2 1468 
Rv0290 pUAB300 f ATCGATCCCAGGAACGGTCCCGCTGAT   27 66.6 1469 
Rv0290 pUAB300/400 r ATCGATCACGCAAATGCGGCACGGA   25 65.1 
Rv0290 in frame for plasmid vectors  
pUAB400 and pUAB300 
 
            
      Rv0291 pUAB400 f ATCGATATTGTTCGCTTGGGTGCTC   25 59.3 1514 
Rv0291 pUAB300 f ATCGATGATTGTTCGCTTGGGTGCTC   26 61.3 1515 
Rv0291 pUAB300/400 r ATCGATTGTCGATTGCCAGGGGTAG   25 60.6 
Rv0291 in frame for plasmid vectors  
pUAB400 and pUAB300 
 
            
        Rv0292 pUAB400 f ATCGATGGAGCCCACCGAATGAAC 
 
24 61.2 1058 
1058 Rv0292 pUAB300 f ATCGATGGGAGCCCACCGAATGAAC   25 62.9 9 
Rv0292 pUAB300/400 r ATCGATGGACTATCTGCGGCGGATGA   26 60.6 
Rv0292 in frame for plasmid vectors  
pUAB400 and pUAB300 
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Name of primer Primer sequence (from 5' to 3') Primer  length 
Tm  
[°C] Gene/ gene fragment amplified 
Product length  
(bp) 
      EsxQ pUAB400 f GGAGATCGATGTGGTGTCGCAGAGTATG 28 60.4 385 
EsxQ pUAB300 f ATCGATCGTGGTGTCGCAGAGTATG 25 60.3 382 
EsxQ pUAB300/400 r ATCGATCGTTTAGTCTCCGGCGTC 24 60.5 
EsxQ in frame for plasmid vectors  
pUAB400 and pUAB300 
 
          
      EsxR pUAB400 f GAGAATCGATGTGATGTCGCAGATTATG 28 57.4 212 
EsxR pUAB300 f ATCGATTGTGATGTCGCAGATTATG 25 55.4 209 
EsxR pUAB300/400 r ATCGATGTGCTAGCCGCCCC 20 62.4 
EsxR in frame for plasmid vectors  
pUAB400 and pUAB300 
 
          
      EsxS pUAB400 f GAGAATCGATGTGATGAGTTTGTTGGATG 29 57.8 315 
EsxS pUAB300 f ATCGATTGTGATGAGTTTGTTGGATG 26 55.8 312 
EsxS pUAB300/400 r ATCGATTTTTAAAACCCGGTGTAGC 25 56.0 
EsxS in frame for plasmid vectors  
pUAB400 and pUAB300 
 
      
      F102 AGAACCACCACGAGGAGCTCAT 22 60.3 
R102 TGATGCCTGGCAGTCGATCGTA 22 60.4 Sequencing primers for pUAB300 insert confirmation  
          
      pUAB400 F TCCCAGAATACCCAGGCGTCCTCT 25 63.5 
pUAB400 R AGGCCCAGTCTTTCGACTGAGCCTTTC 27 63.9 Sequencing primers for pUAB400 insert confirmation  
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2.3.4. PCR amplification 
The M. tuberculosis H37Rv genomic DNA was used as a template for the PCR amplification of the 
gene components of the ESAT-6 gene cluster region 3. The ESX-3 genes, and EsxQ, EsxR and EsxS, 
were amplified using FastStart Taq DNA Polymerase (Roche) as per manufacturers instructions, using 
the GC-rich buffer and annealing temperatures (Tm) as described in Table 2.1. Elongation times were 
calculated at 1 minute per 1kb. The products were separated by agarose gel electrophoresis in a 1.5% 
agarose gel in TAE, and visualised using UV detection. The appropriate bands were excised and the 
DNA purified using the Wizard® SV PCR and Gel Clean-up kit (Promega).  
2.3.5. Cloning vectors 
The desired inserts were cloned into pGemT-Easy (Promega) and subcloned into the ClaI restriction 
sites in the E. coli – mycobacterial shuttle vectors pUAB300 and pUAB400 (Kind gift from A. Steyn, 
University of Alabama at Birmingham). pUAB300 is an episomal vector, encoding resistance for 
hygromycin, while pUAB400 is an integrating vector which confers kanamycin resistance. pUAB300 
and pUAB400 are mycobacterial expression vectors which produce protein fusions of the inserted 
DNA and the mDHFR fragments 1 and 2, and 3 respectively. Interaction of the fusion proteins 
expressed from the vectors allows functional reconstitution of mDHFR and confers resistance to 
trimethoprim. Vectors used in this study are described in Table 2.2. 
2.3.6. Cloning into pGemT-Easy 
The PCR products were ligated into the pGemT-Easy vector (Promega) and transformed into E. coli 
K12 ER2925 cells (NEB). Transformants were selected on LB agar plates with ampicillin (50 ug/ml) 
and PCR screened to verify the presence of the insert. Plasmids were extracted from 10 ml cultures 
using the Wizard® Plus SV Miniprep Plasmid Purification Kit (Promega), quantified and the constructs 
sequenced to confirm the sequence of the insert. 
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Table 2.2.  Vectors used in the identification of protein-protein interactions in ESX-3 
Vector/construct Description Size (bp) Source/Reference 
pGEM-T easy E. coli cloning T-vector, AmpR, lacZ, oriE 3015 Promega 
pUAB400 E. coli-Mycobacterial shuttle vector, integrative,  KanR, groEL promoter, DHFR (3), attP, oriE, int 4720 Singh et al. 2006 
pUAB300 E. coli-Mycobacterial shuttle vector, episomal,  HygR, groEL promoter, DHFR (1,2), 4913 Singh et al. 2006 
pUAB400_ Rv0282 pUAB400 expressing DHFR(3) fused to Rv0282  6649 This study 
pUAB400_ Rv0283 pUAB400 expressing DHFR(3) fused to Rv0283 6383 This study 
pUAB400_ Rv0284a pUAB400 expressing DHFR(3) fused to Rv0284b 6756 This study 
pUAB400_ Rv0284b pUAB400 expressing DHFR(3) fused to Rv0284a 6750 This study 
pUAB400_ Rv0285 pUAB400 expressing DHFR(3) fused to Rv0285 (PE5) 5044 This study 
pUAB400_ Rv0286 pUAB400 expressing DHFR(3) fused to Rv0286 (PPE4) 6312 This study 
pUAB400_ Rv0287 pUAB400 expressing DHFR(3) fused to Rv0287 (EsxG) 5020 This study 
pUAB400_ Rv0288 pUAB400 expressing DHFR(3) fused to Rv0288 (EsxH) 5108 This study 
pUAB400_ Rv0289 pUAB400 expressing DHFR(3) fused to Rv0289 5720 This study 
pUAB400_ Rv0290 pUAB400 expressing DHFR(3) fused to Rv0290 6188 This study 
pUAB400_ Rv0291 pUAB400 expressing DHFR(3) fused to Rv0291 (MycP3) 6234 This study 
pUAB400_ Rv0292 pUAB400 expressing DHFR(3) fused to Rv0292 5778 This study 
pUAB400_ EsxQ pUAB400 expressing DHFR(3) fused to EsxQ (Rv3017c) 5105 This study 
pUAB400_ EsxR pUAB400 expressing DHFR(3) fused to EsxR (Rv3019c) 4932 This study 
pUAB400_ EsxS pUAB400 expressing DHFR(3) fused to EsxS (Rv3020c) 5035 This study 
pUAB300_ Rv0282 pUAB300 expressing DHFR(1,2) fused to Rv0282  6843 This study 
pUAB300_ Rv0283 pUAB300 expressing DHFR(1,2) fused to Rv0283 6577 This study 
pUAB300_ Rv0284 pUAB300 expressing DHFR(1,2) fused to Rv0284b 6950 This study 
pUAB300_ Rv0284 pUAB300 expressing DHFR(1,2) fused to Rv0284a 6944 This study 
pUAB300_ Rv0285 pUAB300 expressing DHFR(1,2) fused to Rv0285 (PE5) 5238 This study 
pUAB300_ Rv0286 pUAB300 expressing DHFR(1,2) fused to Rv0286 (PPE4) 6506 This study 
pUAB300_ Rv0287 pUAB300 expressing DHFR(1,2) fused to Rv0287 (EsxG) 5214 This study 
pUAB300_ Rv0288 pUAB300 expressing DHFR(1,2) fused to Rv0288 (EsxH) 5302 This study 
pUAB300_ Rv0289 pUAB300 expressing DHFR(1,2) fused to Rv0289 5914 This study 
pUAB300_ Rv0290 pUAB300 expressing DHFR(1,2) fused to Rv0290 6382 This study 
pUAB300_ Rv0291 pUAB300 expressing DHFR(1,2) fused to Rv0291(MycP3) 6428 This study 
pUAB300_ Rv0292 pUAB300 expressing DHFR(1,2) fused to Rv0292 5972 This study 
pUAB300_ EsxQ pUAB300 expressing DHFR(1,2) fused to EsxQ (Rv3017c) 5295 This study 
pUAB300_ EsxR pUAB300 expressing DHFR(1,2) fused to EsxR (Rv3019c) 5122 This study 
pUAB300_ EsxS pUAB300 expressing DHFR(1,2) fused to EsxS (Rv3020c) 5225 This study 
pUAB300 Rv0287-88 pUAB300 expressing DHFR(1,2) fused to Rv0287; and Rv0288 (DHFR(1,2)-EsxG, EsxH) 5632 This study 
AmpR – ampicillin resistance; KanR – kanamycin resistance; HygR – hygromycin resistance; oriE – E. coli origin or replication; oriM – 
Mycobacterial origin of replication; DHFR – dihydrofolate reductase fragment; attP – attachment site of phage; int – integrase
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2.3.7. Subcloning into pUAB300 and pUAB400 
The pGem constructs and pUAB300 and pUAB400 vectors were digested with ClaI (Promega). The 
digests were separated electrophoretically and the inserts and digested expression vectors were excised 
and purified. The linearized pUAB300 and pUAB400 vectors were dephosphorylated using Shrimp 
Alkaline Phosphatase (SAP, Roche). The inserts were ligated into the vectors using T4 DNA ligase 
(Promega) and transformed into competent E. coli JM109 cells. Transformants were selected on LB plates 
with hygromycin (100 ug/ml, pUAB300) or kanamycin (50 ug/ml, pUAB400). The size and orientation of 
each insert was verified by PCR amplification using the forward sequencing primer and the insert-specific 
reverse PCR primer. The plasmids were purified and quantified and the sequence and orientation of the 
inserts were confirmed by sequencing. The M-PFC constructs generated in this study are described in 
Table 2.2. 
2.3.8. Transformation of the pUAB400 (pUAB400:ESX-3) constructs into M. smegmatis 
The purified pUAB400 constructs containing the ESX-3 genes were transformed into M. smegmatis 
mc2155 cells and transformants selected for on 7H11 medium containing kanamycin (25 ug/ml). 
Transformants contain the pUAB400 construct integrated into the M. smegmatis genome. Colonies were 
picked and PCR screened to confirm the presence of the insert.  
2.3.9. Cotransformation of pUAB300 constructs (pUAB300:ESX-3) into M. smegmatis  
Electrocompetent cells were prepared for each pUAB400 construct-containing M. smegmatis clone. Each 
pUAB300 construct was transformed individually into each pUAB400 construct-containing M. smegmatis 
clone. Transformants were selected for on 7H11 medium containing kanamycin (25 ug/ml) and 
hygromycin (50 ug/ml). Colonies were screened to confirm the presence of the pUAB300 constructs. 
2.3.10. Identification of interacting protein pairs. 
M. smegmatis clones containing both a pUAB300:ESX-3 and a pUAB400:ESX-3 construct were plated on 
7H11 medium containing kanamycin (25 ug/ml), hygromycin (50 ug/ml) and trimethoprim (15-50 ug/ml), 
and incubated at 37 °C for 10-12 days. Clones which grew on trimethoprim contained proteins which 
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interact, allowing functional reconstitution of mDHFR and conferring trimethoprim resistance. The M. 
smegmatis clones which were positive for growth on trimethoprim contain interacting proteins. Colonies 
from each of the positive clones were resuspended in 7H9 and replated on 7H11 with kanamycin (25 
ug/ml), hygromycin (50 ug/ml) and trimethoprim (15-50 ug/ml) and incubated for 7 days at 37 °C to 
confirm the growth.  
2.3.11. Positive and negative controls 
Rv0287 (EsxG) and Rv0288 (EsxH) have previously been shown to interact (Okkels and Andersen, 2004); 
therefore M. smegmatis containing the pUAB300_Rv0287 and pUAB400-Rv0288 vectors was used as a 
positive control. M. smegmatis containing pUAB300_Rv0287 and the empty pUAB400 vector was used as 
a negative control. 
2.3.12. Graph Editor 
Protein interaction networks were generated using YED graph editor software (Tübingen, Germany, 
www.yWorks.com). 
2.3.13. Protein structure analysis 
The structure and functional domains of the ESX-3 protein components were predicted by in silico 
analysis using protein sequence data from Tuberculist, the TMHMM Server v2.0 transmembrane 
prediction server (TMHMM, http://www.cbs.dtu.dk/services/TMHMM/), SignalP 3.0 signal peptide 
prediction server (SignalP, http://www.cbs.dtu.dk/services/SignalP/) and the Conserved Domain Database 
(CDD, http://ncbi.nlm.nih.gov/Structure/cdd/cdd.shtml). These protein analyses were used in the 
construction of the model of the ESX-3 secretion machinery. 
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2.4. Results  
2.4.1. M-PFC – ESX-3 construct cloning 
The gene components of ESX-3, as well as the genes for EsxQ, EsxR and EsxS, were successfully 
amplified, cloned into pGem-T Easy, and subcloned, in frame, into the M-PFC vectors pUAB300 and 
pUAB400. The sequence and orientation of the inserts were confirmed by sequencing. The integrating 
pUAB400 constructs were transformed into M. smegmatis, and verified by PCR. Competent cultures were 
prepared from single colonies and confirmed by ZN staining. Each episomal pUAB300 construct was 
individually transformed into each pUAB400 construct-containing M. smegmatis and the construct 
presence was confirmed by PCR. 
2.4.2. Optimisation of trimethoprim concentration for selection of interacting proteins 
Initial screening for growth of M. smegmatis containing interacting proteins on media containing 30 ug/ml 
and 50 ug/ml trimethoprim identified only an interaction between Rv0287 (EsxG) and Rv0288 (EsxH). 
Protein interaction between EsxG and EsxH has been previously observed (Okkels and Andersen, 2004). 
The Esx protein pairs have been shown to form tight complexes, a fact which together with their small size 
(~100 aa) may allow high levels of DHFR reconstitution, thereby conferring resistance to high trimethoprim 
concentrations. Many of the other ESX-3 proteins are larger and membrane-associated and likely bind 
less strongly than the EsxG-EsxH dimer; or only interact transiently. We therefore screened for 
interactions between the EsxG, H, Q, R and S proteins, together with the negative control (M. smegmatis 
containing pUAB300_Rv0287 and pUAB400), on trimethoprim concentrations ranging from 15 to 30 ug/ml 
to identify a trimethoprim concentration which consistently allowed for the identification of interacting 
protein pairs, but did not allow growth of the negative control. We expected to see interactions beween the 
Esx proteins pairs EsxG-EsxH and EsxR-EsxS, and possibly EsxQ-EsxS. In addition, homodimerisation of 
the Esx proteins has been previously observed. Trimethoprim concentrations of 20 ug/ml and 25 ug/ml 
both allowed for the identification of various interacting Esx proteins, however only screening on 15 ug/ml 
consistently identified protein interactors in both plasmid combinations; with no growth of the negative 
control within 12-14 days. Therefore all future screenings for interactions were done using 15 ug/ml 
trimethoprim concentration. The use of 15 ug/ml trimethoprim for the identification of interacting proteins is 
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supported by other groups using the M-PFC technique (D. Crossman, S. Sampson, A. Steyn; personal 
communication). 
2.4.3. Interactions between the ESX-3-associated Esx proteins 
The Esx proteins are secreted substrates of the ESX secretion systems. We investigated protein-protein 
interactions between the Esx proteins encoded in ESX-3, and duplicated from it. The M-PFC constructs 
containing the ESX-3-associated Esx genes, EsxG, H, Q, R and S, were transformed into M. smegmatis in 
all possible combinations. Clones containing interacting protein pairs were selected on medium containing 
15 ug/ml trimethoprim. Interactions were detected between the EsxG-EsxH and EsxR-EsxS protein pairs. 
In addition we observed interactions between the other ESX-3 associated ESAT-6/CFP-10 pairs EsxG-
EsxQ, EsxG-EsxR, EsxH-EsxS and EsxQ-EsxS, in both construct combinations. We also observed the 
homodimerisation of each of the Esx proteins examined; as well as interactions between the ESAT-6 
homologs (EsxH, EsxQ and EsxR) and the CFP-10 homologs (EsxG and EsxS). Colonies were observed 
within 4 days for M. smegmatis clones containing an ESAT-6 and CFP-10 homolog, while colonies were 
only observed after 4 days for those clones containing two CFP-10- or ESAT-6-like proteins. In essence, 
all of the ESX-3 associated Esx proteins interacted with themselves and one another (Figure 2.2), 
although stronger growth was observed for those M. smegmatis clones which expressed both an ESAT-6 
and a CFP-10 homolog.  
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Figure 2.2. The ESX-3-associated Esx proteins interact to form hetero- and homo-dimers. The 
ESAT-6 gene cluster region 3-encoded Esx proteins, EsxG and EsxH, and the Esx proteins duplicated 
from region 3, EsxQ, EsxR and EsxS, interact with themselves and with each other. Stronger growth was 
observed in M. smegmatis containing a CFP-10 and ESAT-6 homolog than between two CFP-10 or 
ESAT-6 homologs. EsxG and EsxH are encoded within the ESAT-6 gene cluster region 3; while EsxQ, 
EsxR and EsxS are encoded in a cluster of pe, ppe and esx genes, all duplicated from region 3. The Esx 
proteins represented by squares are ESAT-6 homologs, circles represent CFP-10 homologs. Red arrows 
indicate strong interactions, black arrows indicate weaker interactions. 
2.4.4. The ESX-3 interactome 
In order to construct an interactome of the ESX-3 secretion system, we used M-PFC to identify protein-
protein interactions between all combinations of the ESX-3 proteins. The pUAB400:ESX-3 and 
pUAB300:ESX-3 constructs were cotransformed into M. smegmatis in all possible combinations, and 
clones containing interacting protein pairs were selected on medium containing 15 ug/ml trimethoprim 
(Table 2.3). Each combination of proteins was represented in both vector combinations, and those pairs of 
proteins which resulted in growth of M. smegmatis in both vector combinations were taken as positive  
interactions. In addition, proteins which were shown to interact with themselves (represented in a single 
vector combination), were regarded as positive. Clones expressing both EsxG and EsxH and another 
ESX-3 protein were considered to be positive when either of the Esx proteins was also found to interact 
with the protein of interest. The growth of these M. smegmatis clones containing interacting proteins was 
confirmed by replating on trimethoprim-containing medium. Figure 2.3 is a network of the observed ESX-3 
protein-protein interactions. Specific interactions and their proposed roles are described in the discussion.  
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Table 2.3. Interacting ESX-3 proteins identified by M-PFC 
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Rv0284b     X   X     X   X X X 
Rv0285 X X X X X     X X X X X 
Rv0286   X X X     X X       X 
Rv0287     X X     X X     X   
Rv0288 X         X X X X   X X 
Rv0289 X X X   X   X X     X   
Rv0290   X X X X         X X X 
Rv0291                         
Rv0292 X X X   X X X X X       
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Rv0287-88   X X X   
  
X X         
Protein combinations for which growth was observed on 15 ug/ml trimethoprim are indicated with an X. 
Bold X indicated that growth was observed for M. smegmatis containing the genes in both vector 
combinations. Protein combinations which are shaded in grey were considered to be positive interactions. 
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Figure 2.3. The ESX-3 interactome of protein-protein interactions identified in this study. The M. 
tuberculosis ESX-3 proteins form a complex web of interactions. The proteins are represented in 3 tiers, 
the top tier representing the putative membrane proteins, the lowest the putative ESX-3 substrates and 
the remaining cytoplasmic proteins in the middle.  For simplicity, the Rv0284 is represented as a single 
unit combining the interactions of Rv0284a and b.  
2.4.5. ESX-3 in silico protein structure predictions 
The structure and functional domains of each of the M. tuberculosis ESX-3 secretion system proteins, 
encoded by Rv0282 to Rv0292, were analysed using data from Tuberculist, TMHMM, SignalP and CDD. 
The results obtained are are consistent with those of Bitter et al. (2009).  The properties of these proteins 
were used in constructing a model of the ESX-3 secretion system, based on the protein-protein 
interactions identified and other previously determined interactions and functions of ESX proteins.  
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Rv0282  
Rv0282 is a conserved hypothetical protein of 631 amino acids, which shows homology to SpoVK and 
cbbX-cfxQ family proteins. It contains an AAA+ class ATPase domain of the P-loop NTPase superfamily in 
the region between amino acids 360 and 420. This domain includes Walker A and B motifs, an arginine 
finger and an ATP binding site. ATPases of this family are chaperone-like ATPases involved in the 
assembly and disassembly of protein complexes. No transmembrane helices or signal sequences were 
identified in this protein. Rv0282 appears to be a cytoplasmic ATPase involved in the assembly of protein 
complexes required for ESX-3 secretion. 
Rv0283 
Rv0283 is a possible conserved membrane protein of 538 amino acids. This protein contains a 
hydrophobic transmembrane domain in the N-terminus (Figure 2.4) 
 
Figure 2.4. Rv0283 is an N-terminal membrane protein. The TMHMM profile of Rv0283 indicates that 
this protein contains an N-terminal transmembrane helix. 
Rv0284 
Rv0284 is a conserved membrane protein of 1330 amino acids which contains one (possibly two) N-
terminal transmembrane domain (Figure 2.5) and two cytoplasmic C-terminal ATPases of the P-loop 
NTPase superfamily. Rv0284 shows homology to FtsK-SpoIIIE proteins, which are predicted to be 
involved in the translocation of plasmid or chromosomal DNA during conjugative DNA transfer and septum 
formation (Wu et al., 1994; Begg et al., 1995) and may be responsible for providing the energy for 
translocation of the ESX-3 secreted substrates. 
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.  
Figure 2.5. Rv0284 contains N-terminal transmembrane domains. The TMHMM profile of Rv0284 
identifies an N-terminal transmembrane helix. The TMHMM profiles of homologs of Rv0284 suggest that 
the lower peak adjacent to the transmembrane peak may be a second transmembrane helix. 
Rv0285 (PE5) 
Rv0285 is a PE family protein of 102 amino acids, which contains a putative N-terminal signal peptide with 
a probable cleavage site between amino acid 31 an 32, at the sequence ASA-AP. The PE proteins are 
putative secreted substrates of the ESX secretion systems. 
Rv0286 (PPE4) 
Rv0286 is a member of the PPE family of proteins. The protein is 513 amino acids in length and contains 
a PPE superfamily domain in the N-terminal 160 amino acids. TMHMM analysis of this protein identified 3 
transmembrane domains in the centre of the protein, between amino acids 240 and 340 (Figure 2.6). This 
is not congruent with the PPE proteins from the other ESAT-6 gene clusters (Figure 2.7). The PPE 
proteins encoded in the M. tuberculosis ESAT-6 gene clusters 1, 2 and 5 contain no transmembrane 
motifs, or contain N-terminal signal sequence-like motifs, and are predicted to be secreted by the ESX 
secretion systems. The structure of the PPE4 homolog in M. smegmatis is, however, similar to that of M. 
tuberculosis, also containing three transmembrane domains, suggesting that this structure is essential for 
the functioning of this PPE protein in mycobacteria. 
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A B  
Figure 2.6. Rv0286 (PPE4) contains 3 transmembrane-like domains in the middle of the peptide. 
The PPE proteins encoded by the ESAT-6 gene cluster region 3 of M. tuberculosis (A) and M. smegmatis 
(B) both contain 3 transmembrane domains. 
 
To further investigate the unusual structure of PPE4 generated by TMHMM, we compared the TMHMM 
probability of PPE4 with the PPE proteins that are duplicated from and associated with PPE4 (Figure 2.8, 
Gey van Pittius et al 2006). Similar TMHMM profiles were observed for the PPE proteins which were 
duplicated directly from PPE4, with the features becoming less prominent in the ESX-3 associated PPEs. 
The ESAT-6 gene cluster region 3 is the first duplication of the ESAT-6 gene cluster 4, and the first region 
to contain a PPE protein (N.C. Gey van Pittius, personal communication). It appears, therefore, that the 
structure of the PPE proteins has evolved significantly subsequent to the duplications from PPE4.  
The PPE proteins contain a conserved N-terminal domain, while their C- terminal regions are highly 
variable (Cole et al., 1998; Camus et al., 2002). PPE proteins often occur in an operon with a PE protein, 
with which it interacts (Tundup et al., 2006; Tundup et al., 2008), and the complex of which is secreted by 
its associated ESX secretion system (Abdallah et al., 2006; Abdallah et al., 2009). PPE4 occurs within an 
operon with PE5, in the ESAT-6 gene cluster region 3, and contains the conserved N-terminal PPE 
domain; and the hydrophobic transmembrane-like domains occurring in the more variable C-terminus. It 
appears that the properties of the PPE proteins which result in their secretion by the ESX secretion 
systems are derived from PPE4, while the hydrophobic transmembrane-like domains have been lost in 
subsequent duplications. Therefore we propose that PPE4 is secreted via the ESX-3 secretion machinery 
and subsequently integrated into the mycomembrane via its 3 transmembrane domains. 
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Figure 2.7. The transmembrane structure of PPE4 is unique among the ESAT-6 gene cluster-
encoded PPE proteins. The TMHMM profile of PPE4, encoded by ESX-3 (A), differs considerably from 
those of the PPE proteins encoded by ESX-1 (PPE68, B) and ESX-2 (PPE69, C) which contain no 
hydrophobic transmembrane-like motifs, and the ESX-5-encoded PPEs, PPE25 (D), PPE26 (E) and 
PPE27 (F). Signal sequence-like motifs are observed in the N-terminals of PPE25 and PPE27, but no 
further transmembrane-like motifs are present. 
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Figure 2.8. Transmembrane-like motifs are present in several PPE proteins which are duplicated 
from, or associated with PPE4. The PPE proteins which were duplicated directly from PPE4 (A); PPE46 
(B) and PPE47-48 (C) exhibit TMHMM profiles similar to PPE4, maintaining the 3 mid-protein 
transmembrane domains and 2 hydrophobic stretches further upstream. Additional signal sequence-like 
motifs begin to emerge in the N-terminus. It appears that the PPE proteins have evolved away from this 
structure as although the PPE4-associated protein PPE66-67 (D) exhibits similar structure, these 
properties are less prominent in other PPE proteins associated with PPE4, PPE1 (E), PPE37 (F), PPE20 
(G) and are absent from the ESX-1-encoded PPE68 (H). 
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Rv0287 (EsxG) 
Rv0287 is a CFP-10-like Esx protein of 97 amino acids, a secreted substrate of ESX-3. 
Rv0288 (EsxH) 
Rv0288 is a 96 amino acid ESAT-6-like Esx protein, a potent antigen (TB10.4) secreted by ESX-3. 
Rv0289 
Rv0289 is a conserved hypothetical protein of 295 amino acids, which has a signal sequence-like motif in 
the N-terminus (Figure 2.9), and may therefore be a secreted protein. 
 
Figure 2.9. The N-terminus of Rv0289 contains a signal sequence-like motif. 
Rv0290 
Rv0290 is a conserved integral membrane protein of 472 amino acids which consists of 11 
transmembrane helices (Figure 2.10) and is predicted to be the membrane pore through which the ESX-3 
substrates are transported through the cell membrane (Tekaia et al., 1999; Gey van Pittius et al., 2001). 
 
Figure 2.10. Rv0290 contains 11 transmembrane domains. 
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Rv0291 
Rv0291 is a 461 amino acid membrane anchored, cell wall-associated mycosin (subtilisin-like serine 
protease), MycP3.  MycP3 contains an N-terminal signal-sequence motif and a C-terminal transmembrane 
helix (Figure 2.11), suggesting that most of this protein occurs outside of the cell and is anchored to the 
cell membrane via the C-terminus. The N-terminal is likely cleaved between amino acids 25 and 26 (AWA-
IG), after secretion. This protein contains a peptidase-like motif of the subtilisin superfamily between 
amino acids 75 and 375,  
 
Figure 2.11. Rv0291 is a secreted, membrane anchored mycosin protease. The TMHMM profile 
clearly depicts the N-terminal signal sequence and C-terminal transmembrane domain.   
Rv0292 
Rv0292 is a conserved transmembrane protein of 331 amino acids, which contains two N-terminal 
transmembrane domains (Figure 2.12) of which one might be a signal peptide, as predicted by SignalP, 
and is likely cleaved between amino acids 26 an d 27. 
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Figure 2.12. Rv0292 is a transmembrane protein. Two N-terminal transmembrane domains are 
predicted by TMHMM analyses although one of these may be a signal peptide, as predicted by SignalP 
3.0.  
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2.5. Discussion 
The ESX-3-associated Esx proteins form hetero- and homodimers 
The M-PFC screen of the Esx proteins EsxG, EsxH, EsxQ, EsxR and EsxS indicates that all of these 
proteins can interact as ESAT-6/CFP-10 pairs, as well as ESAT-6/ESAT-6 and CFP-10/CFP-10 pairs, of 
identical and related proteins. This is consistent with the results of other studies which have shown 
interactions between the Esx protein pairs, and detected self-dimerisation of individual Esx proteins 
(Stanley et al., 2003; Okkels and Andersen, 2004; Singh et al., 2006; Teutschbein et al., 2009). 
It has not previously been shown that the Esx proteins interact with other Esx proteins outside of their 
protein pairs, Okkels et al. (2004) specifically showed that EsxG and EsxH do not interact with EsxA and 
EsxB (ESX-1 Esx proteins). However, the EsxQ, EsxR and EsxS proteins are duplicated from EsxG and 
EsxH, and are fairly homologous to these proteins (65-84% identical vs 21-29% identity between 
EsxG/EsxH and EsxB/A), which could explain the ability of these proteins to interact. Interestingly, all five 
ESX-3-associated Esx proteins are under transcriptional regulation by Zur (zinc dependant), together with 
ESX-3 (Maciag et al., 2007). The conservation of the regulation of EsxQ, EsxR and EsxS by Zur 
subsequent to their duplication suggests that their function remains linked to ESX-3. ESX-3 is also 
transcriptionally regulated by IdeR in response to iron (Rodriguez et al., 2002), however only EsxG and 
EsxH are under control of IdeR, suggesting that these Esx proteins may be differentially expressed and 
function under different environmental conditions.  
The physiological importance of the homodimerisation of the Esx proteins remains to be established, as 
these interactions have only been detected in in vitro studies using recombinant proteins and in two-hybrid 
experiments where the protein occurs in the absence of its partner. These proteins may not actually 
interact when coexpressed with their partners, due to the strength of interaction of the heterodimer. 
However, heterotetramers consisting of dimers of the ESAT-6/CFP-10 complex have been observed in 
Western blotting experiments (N.C. Gey van Pittius, personal communication), suggesting that the Esx 
proteins may form larger complexes, lending credibility to these interactions. 
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The membrane proteins of ESX-3 interact to form a membrane complex 
We investigated the interactions between the membrane components of ESX-3. Three ESX-3 membrane 
proteins were found to dimerise in this study; Rv0283, Rv0290 and the N-terminal half of Rv0284 
(Rv0284a). Rv0284a and Rv0284b, the N- and C- terminal halves of Rv0284, also interacted, which is 
expected as they form a single protein. In addition Rv0283, Rv0290 and Rv0292 interact with Rv0284 
(Figure 2.13).  
 
Figure 2.13. The membrane components of ESX-3 interact to form a membrane protein complex. 
The interactions between these membrane proteins have not previously been identified in any of the ESX 
systems, and this may be due to their localisation in the membrane. Rv0283 and Rv0284 possess one 
and two transmembrane domains respectively, while Rv0292 has two transmembrane domains. Rv0290 
consists of 11 transmembrane domains and is predicted to form the membrane pore through which the 
substrates of ESX-3 are secreted. One of the limitations of the yeast-2-hybrid system is its inability to 
identify membrane interactions. In addition, the unique mycobacterial membrane structure may be 
required for proper folding of these proteins or stabilisation of the complex, which would also prevent in 
vitro detection of interactions. 
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Rv0284 is a membrane-associated ATPase, where the N-teminal part of the protein penetrates the 
membrane and the C-terminus contains the ATPase domains. Therefore it appears that the membrane 
section (Rv0284a) interacts with itself and the membrane proteins Rv0283 and Rv0292, while the ATPase 
domains interact with Rv0290. The C-terminal of the homolog of this protein in ESX-1 interacts with CFP-
10 and is predicted to provide the energy for translocation of ESAT-6/CFP-10 through the membrane pore 
(Renshaw et al., 2002; Hsu et al., 2003; Stanley et al., 2003; Guinn et al., 2004; Renshaw et al., 2005; 
Champion et al., 2006). Rv0284 presumably binds to Rv0290 to enable the translocation of EsxG-EsxH 
through the pore structure.  The functions of Rv0292 and Rv0283 have not been established, although the 
ESX-1 homolog of Rv0292 is required for the secretion of ESAT-6 (Brodin et al., 2006) and therefore 
presumably forms an essential part of the secretion complex. These proteins may be involved in the 
stabilisation of the membrane complex, or assist in recruiting the substrates to the secretion machinery. 
The proteins required for the transfer of secreted ESX substrates through the mycomembrane have not 
been identified. We have observed dimerisation of Rv0290, suggesting that this protein may form multiple 
pore structures which may extend through the plasma membrane and mycomembrane to transfer the ESX 
substrates directly from the cytosol into the extracellular milieu, although this interaction and complex 
formation would need to be verified.  
We propose that the membrane proteins Rv0283, Rv0284, Rv0290 and Rv0292 together form a 
membrane complex, possibly incorporating multiple copies of some of the proteins, which, powered by the 
ATPase activity of Rv0284 transfer the ESX substrates directly through the plasma membrane, via a 
channel formed by Rv0290.  
Secreted substrates of ESX-3 interact with a variety of ESX-3 proteins 
It has been suggested that in addition to the Esx protein complex, the ESX secretion systems secrete their 
associated PE-PPE protein complex (Abdallah et al., 2006; Abdallah et al., 2009). Previous studies have 
detected homodimerisation of both PE and PPE proteins, and well as the formation of PE-PPE protein 
complexes (Tundup et al., 2006; Teutschbein et al., 2009). The ESAT-6 gene cluster region 3 encodes the 
PE5-PPE4 protein pair. In this study we detected homodimerisation of PE5 (Rv0285), however we did not 
detect homodimerisation of PPE4 (Rv0286) or complex formation of PE5-PPE4. Tundup et al (2006) 
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suggest that PE and PPE proteins will form homodimers when expressed on their own, and will only form 
heterodimers when co-transcribed and -translated, as interactions between the proteins during translation 
are required for stable complex formation.  
Presuming that PE5 and PPE4 do indeed form a secreted complex, we compared the interacting partners 
of the PE5-PPE4 and EsxG-EsxH complexes. We observed that, with one exception, PE5-PPE4 and 
EsxG-EsxH exhibit identical interactomes. Both complexes interact with the membrane proteins Rv0284 
and Rv0292 and with the cytoplasmic proteins Rv0282 and Rv0289 (Figure 2.14). PE5-PPE4 also 
interacts with Rv0290, via PE5. 
 
Figure 2.14. The putative substrates of ESX-3 have almost identical interactomes. PE5 and PPE4, 
and EsxG-EsxH are proposed to form protein complexes. The combined interactions of each protein pair 
with other proteins encoded by ESX-3 are plotted, and are identical, with the exception of the interaction 
between PE5-PPE4 and Rv0290. In addition the two protein complexes interact with each other. Solid 
arrows depict interactions identified in this study, while dotted arrows represent putative interactions which 
have been shown for related protein pairs. 
Rv0284 is the membrane ATPase which is proposed to provide the energy for ESX substrate translocation 
and is therefore, presumably involved in the secretion of all ESX-3 substrates. Rv0284 binds to both 
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complexes, and through the hydrolysis of ATP allows the secreted complexes to be transported through 
Rv0290. 
Rv0282 is a putative chaperone protein, which has ATPase activity. Rv0282 may be involved in complex 
formation by providing the energy required to cause binding of the proteins. The Rv0282 homolog, 
Rv3868, is required for ESAT-6 secretion (Brodin et al., 2006), and oligomerises to form a hexamer which 
possesses ATPase activity which results in changes to its structure, and may assist in protein-protein 
binding (Ogura et al., 2004; Luthra et al., 2008). Rv0282 also binds to itself, supporting a similar structure 
and function for this homolog. Rv0282 also binds to Rv0284, Rv0289 and Rv0292, suggesting that it may 
rather be involved in catalysing the interaction between the substrate complexes and one or more of these 
proteins. 
The only difference between the interactions of EsxG-EsxH and PE5-PPE4 is the interaction between 
PE5-PPE4 and Rv0290. It has been suggested that the PPE proteins may function as gating proteins 
(Brodin et al., 2006) controlling the secretion of the Esx proteins, as knocking out PPE68 (in ESX-1) 
causes an increase in ESAT-6 secretion. Rv0290 is predicted to form the membrane pore, and binding of 
PPE4 to the pore may obstruct EsxG-EsxH secretion. However, an interaction was only detected between 
PE5 and Rv0290, therefore it is unclear whether this may be the function of PPE4, unless PE5 is an 
anchoring protein which connects PPE4 to Rv0290, to prevent Esx secretion. The PE-PPE complexes are 
predicted to be additional ESX system substrates and therefore the reduction in Esx secretion may rather 
result from competition between the PE-PPE and Esx-Esx complexes for secretion by the ESX system.  
Rv0289 is a cytoplasmic protein with an N-terminal signal sequence-like motif and unknown function. 
Rv0289 interacts with several proteins in addition to PE5-PPE4 and EsxG-EsxH; Rv0282, Rv0283 and 
Rv0284 (Figure 2.15). The ESX-1 homolog of Rv0289, Rv3866, is not required for ESAT-6 secretion, 
however its deletion results in an ESAT-6-independant reduction in virulence (Brodin et al., 2006). This, 
together with the N-terminal signal sequence-like motif, suggests that Rv3866 and Rv0289 may be 
additional substrates of their respective ESX secretion systems. The only difference between the EsxG-
EsxH and Rv0289 interactomes is that Rv0289 binds to Rv0283 and not to Rv0292, which may indicate 
that different membrane proteins are involved in the secretion of different substrates. However, if Rv0289 
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is a secreted substrate, and is secreted independently of the Esx and PE/PPE complexes, the role of the 
interactions between them is unclear. 
 
Figure 2.15. Rv0289 binds to several of the same proteins as the EsxG-EsxH complex 
EsxH and PPE4 were also shown to interact. The interactions between PPE68 and ESAT-6, CFP-10 and 
EsxH have been shown previously (Okkels and Andersen, 2004; Teutschbein et al., 2009). The putative 
ESX-3 substrates PE5-PPE4, EsxG-EsxH and Rv0289 interact with each other. The significance of these 
interactions is unclear, especially as they do not rely on each other for secretion. It has been proposed 
that rather than being substrates, Esx-Esx and PE-PPE form part of the ESX secretion machinery. It is 
also possible that the ESX substrates remain associated with the ESX secretion machinery, and the 
mycobacterial cell, via interactions with the mycomembrane-embedded PPE4. 
The similarity and overlap of the interactions between EsxG and EsxH, and EsxQ, EsxR and EsxS, which 
were duplicated from EsxG and EsxH, suggest that these proteins may also be substrates of ESX-3, 
although this remains to be established. The regulation of expression of these proteins differs from that of 
EsxG and EsxH, in that it is not induced in response to iron starvation (Maciag et al., 2007). Therefore 
EsxQ, EsxR and EsxS may be alternate ESX-3 substrates depending on the conditions in which the 
bacterium resides. 
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Limitations of this study 
In this study we have identified several interactions which have not previously been identified for any of 
the other ESX secretion machineries, however some interactions previously identified between ESX-1 
protein components have not been detected in the ESX-3 homologs. 
The M-PFC technique has been specifically developed to investigate mycobacterial protein-protein 
interactions. Previous studies have utilised in vitro and yeast-2-hybrid techniques, which have lead to the 
exclusion of the identification of most interactions involving membrane proteins. In addition, for most of 
these approaches, the proteins are expressed in unrelated organisms, and may not undergo correct 
folding and post-translational modifications. Expression of mycobacterial proteins in E. coli, and other 
unrelated organisms, is notoriously difficult, often resulting in little or no expression, or the formation of 
inclusion bodies. This is mostly due to the high GC content of mycobacterial genes, as well as toxicity of 
some mycobacterial proteins. M. smegmatis is a heterologous mycobacterial host organism, which, being 
much more closely related to M. tuberculosis, has similar transcription and translation machinery, post-
translational modification mechanisms and a similar membrane structure. Therefore, this technique is 
envisaged to be more efficient in identifying the protein-protein interactions of M. tuberculosis, specifically 
the membrane-associated interactions involved in secretion. 
The technique is, however, not without limitations. There are several reasons why some protein-protein 
interactions may not have been identified during this study. These include the size of the proteins, the 
strength of the interaction, the conformation of the proteins, the location of the protein within the cell and 
competition from endogenous M. smegmatis proteins. The conformation of a protein, and its size, may 
affect the reconstitution of mDHFR, despite the presence of an interaction, thereby preventing the 
identification of the protein-protein interaction. Proteins which interact very weakly, or only interact 
transiently may produce very small amounts of mDHFR which is not sufficient to confer trimethoprim 
resistance to the bacteria. Protein conformation and interactions may also vary during different 
environmental conditions or growth phases. A protein pair may only interact under specific conditions and 
these interactions may remain undetected. In order for resistance to be conferred, both mDHFR fragments 
need to be located within the cell. As many of the ESX-3 components are membrane associated, one or 
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more of these fragments may be located outside of the cell, or within the membrane, preventing the 
detection of the interaction. As M. smegmatis has its own ESX-3 secretion system, some endogenous 
proteins may also interact with the mDHFR-fused proteins, preventing efficient interaction between the 
mDHFR fragments and preventing effective reconstitution of mDHFR, maintaining susceptibility to 
trimethoprim. In addition, some of the proteins may have N-terminal sequences which are cleaved post-
translationally; should this occur, the N-terminal mDHFR fragment would also be cleaved and no 
interactions would be identified with that protein (mycosin-3 is thought to be autocatalyic, cleaving its N-
terminal sequence, and this may explain why no interactions were detected for this protein (Rv0291)). 
Therefore some interactions which might occur between ESX-3 protein components may not have been 
identified within this study due to the above mentioned factors. Further selective cloning experiments of 
various sections of genes are needed to tease out the interactome to completion. 
Non-specific interaction of proteins may also have lead to the identification of false interactions, therefore 
all interactions and their putative roles will need to be confirmed and further investigated. In vivo pull down 
assays, cross-linking studies and Blue Native PAGE (polyacrylamide gel electrophoresis) may be 
employed to further analyse the interactions of this secretion system. 
General discussion 
This is the first study which has attempted to identify protein-protein interactions and determine the 
interactome of the M. tuberculosis ESX-3 secretion system. Several ESX-3 protein-protein interactions 
have been identified. These interactions, together with the putative protein structures and localisations, 
and knowledge gained from other M. tuberculosis ESX secretion systems have been used to generate a 
model of ESX-3 secretion in M. tuberculosis, as proposed in Figure 2.16. This model and the interactions 
identified can serve as a basis for further investigation of the ESX-3 secretory mechanism. Confirming the 
interactions and roles of these proteins in ESX-3 secretion may help to elucidate the mechanism through 
which ESX-3 is involved in divalent metal cation homeostasis, an essential role in M. tuberculosis, and 
may provide novel drug targets for the eradication of tuberculosis disease. 
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Figure 2.16. A model of the ESX-3 secretion machinery. (A) The ESX-3 secretion machinery is 
encoded by the ESAT-6 gene cluster region 3. (B)The membrane proteins Rv0283, Rv0284, Rv0292 form 
a membrane complex with Rv0290, which forms the channel through the plasma membrane. The EsxG-
EsxH, and PE5-PPE4 complexes form directly after translation. Rv0282 oligomerises to form a hexameric 
ATPase. (C) Rv0282 binds to EsxG-EsxH, PE5-PPE4 and Rv0289 and acts as a chaperone, providing 
energy to catalyse the interaction between these proteins and the membrane proteins Rv0284, and 
Rv0283 or Rv0292. (D) Rv0284 is an ATPase which provides the energy for translocation of the ESX-3 
substrates through the Rv0290 membrane channel. (E) EsxG-EsxH and Rv0289 are secreted through the 
mycomembrane via an unknown pore protein, while PPE4 is embedded into the mycomembrane by its 3 
hydrophobic transmembrane domains. PE5 may bind to Rv0290 to facilitate in associating PPE4 with the 
ESX-3 secretion machinery. The substrate(s) and role of mycosin 3 have yet to be determined, as does 
the identity of the mycomembrane channel protein. ATPase domains are represented as diamonds, IM is 
the inner/plasma membrane, MM is the mycomembrane. 
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The construction of a genetic knock-out of the ESX-3 secretion system in 
Mycobacterium smegmatis 
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3.1. Introduction 
The M. smegmatis genome contains 3 of the 5 ESAT-6 gene cluster regions found in M. tuberculosis; 
regions 4, 3 and 1 (Gey van Pittius et al., 2001).  The M. smegmatis ESAT-6 gene cluster region 3 
contains all of the gene components of the M. tuberculosis gene cluster, spanning MSMEG_0615 to 
MSMEG_0626 (Figure 3.1) and encoding the ESX-3ms secretion system. ESX-3 is essential for the in vitro 
growth of M. tuberculosis (Sassetti et al., 2003), however not for the growth of M. smegmatis.  
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Figure 3.1. The ESAT-6 gene cluster region 3 of M. tuberculosis and M. smegmatis. 
In this study we have made a knock-out of ESX-3ms in M. smegmatis. This knock-out will enable the 
investigation of the functions, substrates and other properties of the M. smegmatis ESX-3 and allow 
further investigation into its essential function in M. tuberculosis. M. smegmatis is frequently used as a 
mycobacterial model organism to study M. tuberculosis due to its non-pathogenic nature, rapid growth 
rate and relative ease of manipulation. M. smegmatis and M. tuberculosis have a similar cytosolic 
composition, metabolism, mechanisms of gene expression and protein translation, folding, modifications 
and interactions. Therefore certain parallels may be drawn between what is observed in M. smegmatis 
and that which occurs in M. tuberculosis and other pathogenic mycobacteria. Understanding the function 
and mechanism of this secretion system may enable us to identify ways to interfere with it and to develop 
novel dugs to assist in eradicating tuberculosis disease. 
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3.2. Experimental approach 
The ESAT-6 gene cluster region 3 (ESX-3ms) was deleted from M. smegmatis using homologous 
recombination, as described by Gordhan and Parish (2001). Homologous recombination is a biological 
process during which two DNA strands with similar or identical sequence (homologous DNA) are broken 
and rejoined. This process is used in the repair of double stranded breaks during DNA replication and can 
be manipulated to incorporate, delete and exchange genetic material in the genomes of various 
organisms. 
The technique used to delete the ESX-3ms from M. smegmatis utilizes homologous recombination 
between a specifically constructed suicide vector and the genomic region of interest. The suicide vector is 
a non-replicating plasmid which contains an antibiotic selection marker as well as two DNA sequences 
identical to the DNA up- and downstream of the desired deletion region, located adjacent to one another. 
In addition, counter-selectable markers conferring sucrose-sensitivity and beta-galactosidase activity, may 
be included. A single recombination event between one of the homologous sequences and the genomic 
sequence results in the integration of the entire vector into the genome resulting in antibiotic resistant blue 
colonies (single cross-overs, SCOs) which are sensitive to sucrose. These SCOs are passaged to allow a 
second recombination event to occur between either of the homologous sequences resulting in double 
cross-overs (DCOs) which form sucrose resistant, antibiotic-sensitive white colonies. DCOs may result in 
either the removal of only the vector sequence (reversion to wild-type), or deletion of the desired region 
and the vector sequence (generating a knock-out); depending on the position of the second recombination 
event (Gordhan and Parish, 2001). Schematic outlines of the construction of the suicide vector and the 
homologous recombination events required to create a knockout of the M. smegmatis ESAT-6 gene 
cluster region 3 are given in Figure 3.2a and 3.2b, respectively. 
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Figure 3.2a. Construction of the suicide vector p2NIL_R3 KO used to knock out the ESAT-6 gene 
cluster region 3 of M. smegmatis. DNA sequences of 800bp upstream and downstream of the ESAT-6 
gene cluster region 3 are amplified from M. smegmatis genomic DNA and cloned into the suicide vector 
p2NIL to generate p2NIL_R3 UpDownsmeg. The PacI cassette, containing the sacB and lacZ genes, is 
ligated into p2NIL_R3 UpDownsmeg to generate the knockout construct p2NIL_R3 KO. The aph and bla 
genes confer kanamycin and ampicillin resistance respectively. 
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Figure 3.2b. Constructing a M. smegmatis ESAT-6 gene cluster region 3 knock-out by homologous recombination. The knock-out construct, 
p2NIL_R3 KO, is transformed into M. smegmatis. A single recombination event integrates the vector into the M. smegmatis genome, up or 
downstream of the ESAT-6 gene cluster region 3. A second recombination event is allowed to occur and results in either reversion to wild-type or 
generation of a knock-out of the ESAT-6 gene cluster region 3 (ESX-3ms). 
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3.3. Materials and Methods 
All standard molecular techniques were performed essentially as described by Sambrook et al., (1989). 
Techniques and reagents are described in detail in Appendix A.  
3.3.1. Bacterial strains 
E. coli strain JM109 was used in cloning procedures. M. smegmatis mc2155 was used to make the M. 
smegmatis ESAT-6 gene cluster region 3 knock-out (ESX-3ms KO).  
3.3.2. Media and culture conditions 
E. coli was cultured in Luria-Bertani (LB) broth with shaking, and on LB agar plates, overnight at 37 °C.  
Solid and liquid media were supplemented with the antibiotics ampicillin (50 ug/ml, Roche) and kanamycin 
(50 ug/ml, Sigma) and solid media with X-gal (Roche) and 5% sucrose, as appropriate. 
M. smegmatis was grown in liquid LB with shaking, and on LB agar plates, for 4-5 days at 37 °C.  Liquid 
media was supplemented with 0.1% Tween-80, and kanamycin (25 ug/ml, Sigma) when required. Solid 
media was supplemented with kanamycin (25 ug/ml, Sigma), X-gal (Roche) and 5% sucrose, as 
appropriate. 
3.3.3. Transformations 
Transformation was performed by electroporation of electrocompetent cells. E. coli was transformed at 2.5 
kV, 25 µF, 125 µFd, 200 Ώ. One millilitre of SOC was added to the transformed cells which were 
expressed for 1 hour at 37 °C before plating. M. smegmatis was transformed at 2.5 kV, 25 µF, 125 µFd, 
1000 Ώ followed by the addition of 1 ml LB medium and expression for 3 hours at 37 °C before plating. 
3.3.4. Cloning vectors 
The desired PCR products were cloned into pGemT-Easy (Promega) and subcloned into the p2NIL 
mycobacterial suicide vector. The PacI cassette containing the sacB and lacZ genes was digested from 
the pGOAL17 vector and cloned into the PacI restriction site in p2NIL. The vectors used in this study are 
described in Table 3.1. 
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Table 3.1 Vectors used in the construction of the M. smegmatis ESX-3ms KO. 
Name Description Size (bp) Source/Reference 
pGEM-T easy E. coli cloning T-vector, AmpR, lacZ, oriE 3015 Promega 
p2NIL E. coli cloning vector,  mycobacterial suicide 
vector, oriE, KanR 
4753 Parish and Stoker 2000 
pGOAL17 Plasmid with lacZ and sacB genes 
in PacI cassette, oriE, AmpR 
8855 Parish and Stoker 2000 
AmpR – ampicillin resistance; lacZ – β-galactosidase activity; oriE – E. coli origin of replication; KanR – 
kanamycin resistance; sacB – levansucrase activity 
3.3.5. Primers 
All M. smegmatis mc2155 DNA sequence information was obtained from the JVCI CMR Mycobacterium 
smegmatis MC2 Genome Page (http://cmr.jcvi.org/tigr-scripts/CMR/GenomePage.cgi?org=gms). Primers 
R3 Upsmeg f & r and R3 Downsmeg f & r were designed to amplify approximately 800bp of DNA directly 
upstream and downstream of the ESAT-6 gene cluster region 3 of M. smegmatis, with KpnI and BglII, and 
BglII and HindIII restriction sites respectively, to facilitate cloning into the suicide vector p2NIL. Additional 
primers, R3 F1 f & r and R3 KO f & r, were designed to distinguish between DCO colonies which may be 
wild-type M. smegmatis or the ESX-3ms KO. The primers used in this study are described in Table 3.2 and 
Figure 3.3. 
Table 3.2 Primers used in the construction of the M. smegmatis ESX-3ms KO. 
  Name Sequence (5’ – 3’) 
Length 
(bp) 
Tm 
(°C) 
Restriction 
site 
A R3 Upsmeg f GGGGTACCGGAGCATCCGCTGCAGACC 27 64 KpnI 
B R3 Upsmeg r GGGGAGATCTCTCTCCCTTATGTATGCC 28 54 BglII 
C R3 Downsmeg f GGGGAGATCTCGATCCCAGTGCTCCCACA 29 62 BglII 
D R3 Downsmeg r GGGGAAGCTTCCCGAGCGATCCTTTCC 27 56 HindIII 
E R3 F1 f GCAGTGGTTCTCCGAGCGTGG 21 70 n/a 
F R3 F1 r ACGACGTCCGACCAGCGTTGG 21 70 n/a 
G R3 KO f TCCTTCTTTGCGCTGGTCTT 20 60 n/a 
H R3 KO r TGTCGCTGCCGTGGTTCT 18 58 n/a 
Restriction enzyme recognition sites are underlined. 
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Figure 3.3. PCR primers used in the construction and verification of the M. smegmatis ESX-3ms KO.  
(a.) Primers R3 Upsmeg f (A) and R3 Upsmeg r (B), and R3 Downsmeg f (C) and R3 Downsmeg r (D) 
were used to amplify 826bp of DNA sequence upstream and 829bp of DNA sequence downstream of the 
M. smegmatis ESAT-6 gene cluster region 3, respectively. (b.) The R3 F1 f (E) and R3 F1 r (F) primers 
amplify a 798bp DNA sequence upstream of and overlapping the ESAT-6 gene cluster region 3, and will 
generate a product in wild-type and SCO, but not ESX-3ms KO M. smegmatis. (c.) R3 KO f  (G) and R3 KO 
r (H) primers bind to sequences up and downstream of the ESAT-6 gene cluster region 3 and will amplify 
an 820bp DNA fragment only in M. smegmatis ESX-3ms  KO and SCO strains. 
3.3.6. PCR amplification of R3 Upsmeg and R3 Downsmeg 
M. smegmatis mc2155 genomic DNA was used as a PCR template for the amplification of DNA 
sequences up- and downstream of the ESAT-6 gene cluster region 3 (ESX-3ms). The DNA sequences 
upstream and downstream of the M. smegmatis gene cluster region 3 were PCR amplified with FastStart 
Taq DNA Polymerase (Roche), using the primers R3 Upsmeg f & r, and R3 Downsmeg f & r. The resultant 
products were named R3 Upsmeg and R3 Downsmeg respectively. The PCR products were separated by 
agarose gel electrophoresis, the appropriate bands excised and the DNA purified using the Wizard® SV 
PCR and Gel Cleanup Kit (Promega).  
3.3.7. Cloning into pGemT-Easy 
The purified R3 Upsmeg and R3 Downsmeg PCR products were ligated into the pGemT-Easy vector and 
transformed into E. coli. Transformants were selected for on LB agar plates with ampicillin (50 ug/ml) and 
PCR screened to verify the presence of the insert. Plasmids were extracted from 10 ml cultures using the 
Wizard® Plus SV Miniprep Plasmid Purification Kit, quantified and the inserts sequenced to confirm the 
sequence of the insert. The constructs were named pGemR3 Upsmeg and pGemR3 Downsmeg. 
ESAT-6 gene cluster region 3 DOWN UP 
E
F 
ESAT-6 gene cluster region 3 DOWN UP 
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B
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H
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3.3.8. Construction of the M. smegmatis ESAT-6 gene cluster region 3 knockout construct. 
pGemR3 Upsmeg and pGemR3 Downsmeg were digested with KpnI and BglII, and BglII and HindIII 
respectively, simultaneously ligated into the KpnI and HindIII restriction sites of p2NIL, and transformed 
into E. coli. Transformants were selected on LB with kanamycin (50 ug/ml), and the construct was verified 
by colony PCR using the R3 Upsmeg f & r, R3 Downsmeg f & r and R3 Upsmeg f & R3 Downsmeg r 
primer sets and named p2NIL_R3 UpDownSmeg.  
pGOAL17 was digested with PacI, generating two bands of 2.3kb and 6.3kb each. The 6.3kb fragment, 
containing a sacB and lacZ gene was ligated into the PacI site of p2NIL_R3 UpDownSmeg and 
transformed into E. coli. Blue colonies were selected on LB with kanamycin (50 ug/ml) and X-gal and 
verified by duplicate plating on LB with kanamycin (50 ug/ml) and 5% sucrose. The ESAT-6 gene cluster 
region 3 knockout construct, p2NIL_R3 KO, was isolated from clones which did not grow on sucrose-
containing medium. 
3.3.9. Generating the M. smegmatis ESAT-6 gene cluster region 3 knock-out 
Wild-type M. smegmatis was transformed with 1 ug of the p2NIL_R3 KO plasmid and blue SCO colonies 
were selected on LB agar containing kanamycin (25 ug/ml) and X-gal. SCO colonies were picked and 
verified by lack of growth on LB containing 5% sucrose and colony PCR using primers R3 F1 f & r and R3 
KO f & r. Both PCR reactions will amplify in SCOs.  
Verified SCOs were passaged without selection in LB and plated on LB agar with 5% sucrose and X-gal 
and incubated at 37ºC for 3-4 days. White colonies, which are putative DCOs, were selected and 
inoculated into LB medium. Cultures were replica-plated on LB with 5% sucrose and X-gal, and LB with 
kanamycin (25 ug/ml) and X-gal to verify the DCO. DCOs will not grow on kanamycin-containing medium.  
Colony PCRs were done on verified DCOs to distinguish between wild-type and ESX-3ms KOs, using the 
primers R3 F1 f & r and R3 KO f & r. Wild-type M. smegmatis produces products for the PCR reaction R3 
F1 but not for the R3 KO PCR. The ESX-3ms KO will only produce a product for the R3 KO PCR. The R3 
KO amplicon was sequenced to verify the knock-out. 
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3.4. Results  
The 800bp DNA sequences upstream and downstream of the M. smegmatis ESAT-6 gene cluster region 
3 were successfully PCR amplified from M. smegmatis mc2155 genomic DNA (Figure 3.4a), cloned into 
pGemT-Easy and subcloned into the p2NIL suicide vector and confirmed by colony PCR (3.4b). This 
vector was called p2NIL_UpDownSmeg. Subsequent cloning of the pGOAL17 fragment containing the 
lacZ and sacB genes into p2NIL_R3 UpDownSmeg generated a construct, p2NIL_R3KO, which confers 
beta-galactosidase activity, kanamycin resistance and sucrose sensitivity to transformed cells.  
                1         2        3        4       5                                          1        2        3        4 
          a.                            b.     
                 1.5% agarose gel in TAE                                                              1.5% agarose gel in TAE 
Figure 3.4. Construction of the M. smegmatis ESAT-6 gene cluster region 3 knock-out construct 
p2NIL_R3KO. (a.) The R3 Upsmeg (lane 2, 826bp) and R3 Downsmeg (lane 4, 829bp) PCR products 
were PCR amplified from M. smegmatis genomic DNA. Lane 1 is GeneRuler 100bp DNA Ladder Plus, 
lanes 3 and 5 are negative controls. (b.) The p2NIL_R3 UpDownsmeg construct contains both R3 
Upsmeg  (lane 2, 826bp) and R3 Downsmeg (lane 3, 829bp), situated adjacent to one another (lane 4, 
1655bp).  
The p2NIL_R3 KO construct was transformed into M. smegmatis mc2155 resulting in blue SCO colonies 
on LB medium containing X-gal and kanamycin. LB medium was used for the growth of all cultures used 
to generate the knock-out, as Middlebrook 7H9 and 7H11 media contain dextrose which is converted by 
the product of the sacB gene, levansucrase, into a toxic product, preventing the growth of the bacteria. 
The SCO colonies were confirmed by PCR (Figure 3.5) as well as replica plating on LB medium with and 
without sucrose to confirm the presence of the sacB gene. SCOs did not grow on the plates containing 
sucrose. 
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            1   2   3   4   5   6   7   8  9 10 11 12                                1   2  3   4   5   6    7  8   9  10 11 12 
      A.                      B.  
           1.5% agarose gel in TAE                                                                    1.5% agarose gel in TAE 
Figure 3.5. M. smegmatis SCO colonies generated during the construction of the  
M. smegmatis ESX-3ms KO. Colony PCR was used to verify putative SCO colonies. SCOs are positive 
for amplification of 798bp PCR products with primers R3 F1 f & r (A) and 820bp PCR products with 
primers R3 KO f  & r (B). Lanes 2, 4, 5, 6, 7, 8, 9, 10 and 11 contain SCOs. Lane 1 contains GeneRuler 
100bp DNA Ladder Plus and Lane 12 is a negative control.  
SCOs were passaged without selection to allow a second recombination event to occur. Cultures were 
plated on LB medium containing sucrose and X-gal to select for clones without the aph, lacZ and sacB 
genes which are lost during a second cross-over event. White colonies were selected and replica plated 
on LB with sucrose and X-gal and LB with kanamycin. Clones which formed white colonies on sucrose-
containing medium, and showed no growth on kanamycin were confirmed as DCOs. PCR was used to 
distinguish between wild-type and ESAT-6 gene cluster region 3 knock-out (ESX-3ms KO) DCOs. Two of 
the isolated DCOs were found to be ESX-3ms KOs (Figure 3.6). Sequencing confirmed the absence of the 
ESAT-6 gene cluster region 3 from these cultures. Glycerol freezer stocks of these cultures were made 
and stored at -80ºC for future applications. 
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                1   2   3   4   5   6   7  8   9 10 11 12 13 14 15 16 17           
         a.  1.5% agarose gel in TAE 
                1   2   3   4   5   6   7  8   9 10 11 12 13 14 15 16 17 
        b.  1.5% agarose gel in TAE 
 
Figure 3.6.  Identification of the M. smegmatis ESX-3ms KO.  Colony PCR was used to distinguish 
between DCO colonies which contained wild-type and R3 KO M. smegmatis. Wild-type M. smegmatis 
produces a 798bp PCR product with primers R3 F1 f & R (a). R3 KOs produce 820bp PCR products with 
primers R3 KO f & r (b). Lane 1 contains GeneRuler 100bp DNA Ladder Plus. Lanes 2, 3, 6, 8 and 13 are 
wild-type M. smegmatis. Lanes 4 and 7 are M. smegmatis R3 KOs. Lane 2 is an M. smegmatis wild-type 
control. Lane 17 is a negative control. The remaining lanes are SCOs, mixed wild-type and R3 KO 
colonies or inconclusive PCR results.  
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3.5. Discussion  
This study describes the construction of an M. smegmatis ESAT-6 gene cluster region 3 knock-out strain, 
M. smegmatis ESX-3ms KO, using homologous recombination. The construction of this knock-out strain 
confirms the non-essential nature of the ESAT-6 gene cluster region 3 in M. smegmatis. This knock-out 
strain may be used in various comparative studies with the M. smegmatis wild-type strain to identify 
differences in their proteomes, metabolomes and secretomes, as well as other properties, thereby 
enabling the identification of functions and substrates of the M. smegmatis ESX-3 secretion system, which 
could be informative regarding the M. tuberculosis ESX-3. It also provides an opportunity to study inter-
region interactions. This may highlight reasons for the essential nature of this secretion system in M. 
tuberculosis and allow us to expand our knowledge and understanding of the immunopathologically 
important ESX secretion systems and the mechanisms of pathogenesis and survival of M. tuberculosis, 
and may help to identify new drug and vaccine targets for the treatment and prevention of tuberculosis. 
Recently, a conditional ESX-3 mutant of M. tuberculosis was constructed (Serafini et al., 2009). 
Repression of ESX-3 expression in this mutant was lethal to the bacterium, however the phenotype can 
be complemented by zinc, iron and wild-type culture supernatant. This clearly indicates that M. 
tuberculosis ESX-3 secretes factors which are involved in iron and zinc uptake. M. tuberculosis ESX-3 
expression is regulated by iron and zinc (Rodriguez et al., 2002; Maciag et al., 2007), supporting this role 
for ESX-3 in metal cation homeostasis. The fact that M. smegmatis ESX-3 expression is also regulated by 
iron suggests a level of conservation of function between species (Maciag et al., 2009). Therefore the M. 
smegmatis ESX-3ms knock-out may enable further investigation of ESX-3’s role in metal cation 
homeostasis.  
Chapter 4 investigates the secretion of M. tuberculosis EsxH by the M. smegmatis ESX-3ms KO strain in 
comparison to the M. smegmatis wild-type strain in an attempt to characterize the role of ESX-3ms in EsxH 
secretion, and the functional conservation of the ESX-3 secretion system between the two mycobacterial 
species. In addition, the M. smegmatis ESX-3ms KO is currently being used in a comparative study with 
the M. smegmatis wild-type strain to identify variations in their metabolomes, in collaboration with Dr Loots 
at North-West University.  This will form the basis of further studies. 
CHAPTER 4 
 
Investigation of Mycobacterium tuberculosis EsxH secretion by the 
Mycobacterium smegmatis ESX-3 secretion system 
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4.1. Introduction 
The M. smegmatis genome contains three of the ESAT-6 gene clusters present in the M. tuberculosis 
genome, namely ESAT-6 gene cluster regions 4, 3 and 1(Gey van Pittius et al., 2001), each encoding an 
ESX secretion system. The M. tuberculosis ESAT-6 gene clusters encode several immunogenic Esx 
proteins which have been identified in the culture filtrates of M. tuberculosis; including EsxA (ESAT-6) and 
EsxB (CFP-10) from region 1, and EsxH (TB10.4) from region 3 (Andersen et al., 1995; Berthet et al., 
1998; Skjot et al., 2000). 
The ESX-1 secretion system is responsible for secretion of the EsxAB (ESAT-6/CFP-10) protein complex. 
Converse and Cox (2004) have shown that the M. smegmatis ESX-1 secretion system is able to secrete 
M. tuberculosis EsxAB. This secretion system is not involved in virulence in the saprophytic M. 
smegmatis, but has rather been shown to be involved in conjugal DNA transfer (Flint et al., 2004; Coros et 
al., 2008), which has not been observed in M. tuberculosis. Despite this, the M. tuberculosis ESX-1 can 
complement the ESX-1 DNA conjugation phenotype in an M. smegmatis ESX-1 mutant (Flint et al., 2004). 
These data indicate that the ESX-1 secretion system is functionally conserved between these two species 
and may perform additional, as yet unidentified functions in both species. 
Both M. smegmatis and M. tuberculosis also contain the ESAT-6 gene cluster region 3, encoding ESX-3. 
Encoded in this region are the Esx family proteins EsxG and EsxH, which form an EsxGH complex 
(Okkels and Andersen, 2004). EsxH was identified in the culture filtrates of M. tuberculosis and initially 
named TB10.4 (Skjot et al., 2000). EsxH is a potent immunogen, suggesting that it is highly expressed 
during infection. To determine whether the ESX-3 secretion systems of M. tuberculosis and M. smegmatis 
are functionally conserved, we investigated the secretion of M. tuberculosis EsxGH by the M. smegmatis 
wild type and ESX-3ms knock-out strains, and those complemented with the M. tuberculosis ESX-3. 
ESX-3 is essential in M. tuberculosis (Sassetti et al., 2003), but not in M. smegmatis, suggesting that this 
secretion system either performs different functions in the two species, or that the two species have 
different requirements for survival. M. tuberculosis ESX-3 expression is regulated by iron and zinc 
(Rodriguez et al., 2002; Maciag et al., 2007), while M. smegmatis ESX-3 is only regulated by iron (Maciag 
et al., 2009), indicating that at least regulation of ESX secretion in these two species is not identical. 
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Determining whether M. smegmatis ESX-3 is able to secrete M. tuberculosis EsxGH may be a first step 
toward establishing whether ESX-3 is also functionally conserved between these two species, which will 
help to validate the use of the M. smegmatis ESX-3 knock-out to determine the function of ESX-3 in M. 
tuberculosis.  
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4.2. Experimental approach 
This study investigates the secretion of M. tuberculosis EsxH (TB10.4) by the M. smegmatis ESX-3 
secretion system.  Western blotting, employing a mouse anti-TB10.4 antibody is used to identify EsxH in 
the whole cell lysate (WCL) and culture filtrate (CF) fractions of M. smegmatis wild-type and ESX-3ms KO 
strains expressing either EsxG and EsxH, or the entire M. tuberculosis ESX-3 secretion system. 
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4.3. Materials and Methods 
All standard molecular techniques were performed essentially as described by Sambrook et al., (1989). 
Techniques and reagents are described in detail in Appendix A.  
4.3.1. Bacterial strains 
M. smegmatis mc2155 (Snapper et al., 1990) and the M. smegmatis mc2155 ESX-3ms knock-out strain 
(Chapter 3) were used for EsxH secretion analyses. 
4.3.2. Media and culture conditions 
M. smegmatis was grown in Middlebrook 7H9 medium with shaking, and on BBLTM Seven H11 Agar Base 
plates, at 37 °C for 3-4 days or as otherwise stated. Solid and liquid media were supplemented with 0.5% 
glycerol, 0.5% glucose and 0.2% Tween-80. Hygromycin (50 ug/ml) was added as appropriate.  
For secretion studies cultures were grown in Kirchener’s minimal medium supplemented with hygromycin 
(50 ug/ml) when necessary. 
4.3.3. Construction of M. smegmatis strains for the TB10.4 secretion study 
The pYUB412_ESX-3mtb, pUAB300_Rv0287-0288 and p19Kpro_EsxGH vectors (Table 4.1) were 
individually transformed into M. smegmatis and M. smegmatis ESX-3ms KO and plated on 7H11 plates 
containing hygromycin. Colonies were picked and inoculated into 7H9 medium with hygromycin and 
incubated at 37 °C with shaking for 2 days. M. smegmatis and M. smegmatis ESX-3ms KO were grown in 
7H9 without hygromycin. The M. smegmatis WT and ESX-3ms KO strains, and those containing 
pUAB300_Rv0287-0288, p19Kpro_EsxGH and pYUB412_ESX-3mtb were confirmed by PCR using the R3 
KO f & r, R3 F1 f & r and F102 & R102, p19Kpro_EsxG sense & p19Kpro_EsxH antisense, and Rv0282 f 
& r, Rv0285 f & r, Rv0292 f & r primers, respectively (Table 4.2). The different strains constructed and 
used in this study are described in Table 4.3.  
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Table 4.1. Vectors used in the EsxH secretion study 
Name Description Size (bp) Source/ 
Reference 
pYUB412_ESX-3mtb Integrative cosmid containing 181kb M. 
tuberculosis DNA including the ESAT-6 
gene cluster region 3. oriE, cosA, cosB, 
attP, int, HygR, AmpR 
189744 A kind gift from 
N.C. Gey van Pittius 
 
pUAB300_Rv0287-0288 E. coli-Mycobacterial shuttle vector 
containing Rv0287 and Rv0288, episomal,  
HygR, groEL promoter, DHFR (1,2), oriM, 
oriE 
5603 Chapter 2 
p19Kpro_EsxGH E. coli-Mycobacterial shuttle expression 
vector containing EsxG and EsxH (Rv0287 
and Rv0288) HygR, oriE, oriM, 19 kDa 
antigen promoter 
6153 A kind gift from 
Z. Fang 
oriE – E. coli origin or replication; cosA – cohesive end site A; cosB – cohesive end site B; ; attP – 
attachment site of phage; int – integrase; HygR – hygromycin resistance; AmpR – ampicillin resistance; 
DHFR – dihydrofolate reductase fragment; oriM – Mycobacterial origin of replication 
Table 4.2. Primers used in the EsxH secretion study. 
Name Sequence (5’ – 3’) Length 
(bp) 
Tm  
(°C) 
Product size  
(bp) 
R3 F1 f GCAGTGGTTCTCCGAGCGTGG 21 70 
R3 F1 r ACGACGTCCGACCAGCGTTGG 21 70 
798 
(WT only) 
R3 KO f TCCTTCTTTGCGCTGGTCTT 20 60 
R3 KO r TGTCGCTGCCGTGGTTCT 18 58 
820  
(ESX-3ms KO only) 
F102 AGAACCACCACGAGGAGCTCAT 22 60.3 
R102 TGATGCCTGGCAGTCGATCGTA 22 60.4 800 
Rv0282 pUAB300 f ATCGATGATGGCGGGCGTAGGTGAA   25 64.0 
Rv0282 pUAB300/400 f ATCGATCGTGGTCGTGCTGCTGGTT   25 64.4 1930 
Rv0285 pUAB300 f ATCGATCATGACGTTGCGAGTGGTTCC   27 62.4 
Rv0285 pUAB300/400 f ATCGATTGCTCAGCCGCCCACGAC   24 65.6 325 
Rv0292 pUAB300 f ATCGATGGGAGCCCACCGAATGAAC   25 62.9 
Rv0292 pUAB300/400 f ATCGATGGACTATCTGCGGCGGATGA   26 63.2 1059 
esxGp19 sense GGATCCAGGCGGAGATGTTATGAGCCT 
TTTGGA 
33 65.3 
esxHp19 antisense ATCGATTTAGTGGTGGTGGTGGTGGTG 
GCCCCATTTGGCGGCTTCGG 
47 73.5 
654 
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Table 4.3. M. smegmatis strains constructed and used in the EsxH secretion study 
Name Description Source/Reference 
M. smegmatis WT Wildtype M. smegmatis mc2155 (Snapper et al., 1990) 
M. smegmatis WT + ESX-3mtb Wildtype M. smegmatis mc2155 
 containing pYUB412_ESX-3mtb 
This study 
M. smegmatis WT + EsxGH Wildtype M. smegmatis mc2155 
containing pUAB300_Rv0287-88 
This study 
M. smegmatis ESX-3ms KO M. smegmatis mc2155 ESX-3ms KO Chapter 3 
M. smegmatis ESX-3ms KO  + ESX-3mtb M. smegmatis mc2155 ESX-3ms KO 
containing pYUB412_ESX-3mtb 
This study 
M. smegmatis ESX-3ms KO + EsxGH M. smegmatis mc2155 ESX-3ms KO 
containing pUAB300_Rv0287-88 
This study 
M.smegmatis WT + EsxGH-His M. smegmatis mc2155 WT  
containing p19Kpro_EsxGH 
This study 
M.smegmatis ESX-3ms KO + EsxGH-His M. smegmatis mc2155 ESX-3ms KO 
containing p19Kpro_EsxGH 
This study 
4.3.4. Culturing of M. smegmatis for secretion analyses 
Each of the M. smegmatis strains used for the secretion analysis (Table 4.3) was inoculated into 10 ml 
7H9 with hygromycin, when appropriate. Cultures were grown, with shaking, at 37 °C to mid-log phase 
(OD600 = 0.8). Cultures were washed twice with Kirchener’s medium with 0.2% Tween-80, and inoculated 
into 100 ml fresh Kirchener’s medium without Tween-80, to OD600 = ~0.05. Cultures were grown, with 
shaking, at 37 °C to OD600 = ~0.4, to prevent the lysis of cells in culture.  
4.3.5. Secretion analysis 
M. smegmatis cultures were fractionated into the cell pellet and culture supernatant fractions by 
centrifugation. The whole cell lysate was extracted by mechanical cell lysis, by ribolyzing, and the proteins 
from the culture filtrate were acetone precipitated, as described in Addendum A. His-tagged proteins were 
purified from cultures containing p19Kpro_EsxGH using the MagneHis™ Protein Purification System 
(Promega) essentially according to manufacturers instructions, as described in Addendum A.  
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The concentrations of the protein fractions were determined spectrophotometrically using the Bio-Rad 
Protein Assay as described by the manufacturer, according to the microtitre plate protocol. All samples 
were read in duplicate, at three dilutions and the protein concentrations determined using a Bovine Serum 
Albumin (BSA) protein standard curve. 
The culture filtrate and whole cell lysate proteins were separated by SDS-PAGE (sodium dodecyl sulphate 
– polyacrylamide gel electrophoresis). Five micrograms of each whole cell lysate sample, and 2 ug of 
each culture filtrate sample, or 10 ul of His-purified protein were loaded on a 3-18% SDS-PAGE gel and 
electrophoresed at 150 V. Purified recombinant TB10.4 protein (1 ug, A kind gift from P. Anderson) was 
used as a positive control and purified recombinant GroEL protein (1 ug, Colorado State University (CSU)) 
as a negative control and to eliminate false positive results due to cell lysis. Gels were run in duplicate. 
One gel was stained with silver nitrate to visualise the proteins. Western blotting was done on the second 
gel, using mouse anti-TB10.4 primary antibody (1 in 12 dilution, A kind gift from P. Anderson) or anti-His 
(C-terminal) antibody (1 in 5000 dilution, Invitrogen), and goat anti-mouse IgG-HRP (horseradish 
peroxidase) secondary antibody (1 in 5000 dilution, Invitrogen) and detected using the ECL Plus Western 
Blotting Detection System (Amersham™). Membranes were stripped and reprobed using the 
HisDetector™ Western Blot Kit, HRP Colorimetric detection kit (Kirkegaard & Perry Laboratories (KPL)), 
as described by the manufacturer, when appropriate. 
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4.4. Results 
4.4.1. Construction of M. smegmatis strains for EsxH secretion analysis 
The pYUB412_ESX-3mtb, pUAB300_Rv0287-0288 and p19Kpro_EsxGH constructs were transformed into 
the M. smegmatis WT and ESX-3ms KO strains to create the following strains; M. smegmatis WT + ESX-
3mtb, M. smegmatis WT + EsxGH, M. smegmatis ESX3 KO  + ESX-3mtb, M. smegmatis ESX-3ms KO + 
EsxGH. Transformants were selected on 7H11 medium with hygromycin and PCR screened to confirm the 
relevant genotypes (Figure 4.1). 
             1     2       3         4      5       6       7                            1      2      3       4       5      6      7      
     A.                  B.  
                   1.5% agarose gel in TAE                                                          1.5% agarose gel in TAE 
            1     2       3      4      5       6     7                                  1      2      3       4       5       6        7      
    C.                      D.  
                  1.5% agarose gel in TAE                                                        1.5% agarose gel in TAE 
Figure 4.1. PCR confirmation of the M. smegmatis strains used for EsxH secretion analysis. The M. 
smegmatis strains were confirmed by PCR using various primer sets; A. R3 KO f&r, B. R3 F1 f&r, C. F102 
& R102. Lane 1 is GeneRuler 100bp DNA Ladder Plus (Fermentas); Lane 2-4 are M. smegmatis ESX-3ms 
KO containing either no vector (2), pYUB412_ESX-3mtb (3) or pUAB300_Rv0287-0288 (4);  Lane 5-7 are 
M. smegmatis WT containing either no vector (5), pYUB412_ESX-3mtb (6) or pUAB300_Rv0287-0288 (7). 
D. The presence of the M. tuberculosis ESX-3 in M. smegmatis strains containing pYUB412_ESX-3mtb 
confirmed by PCR amplification of Rv0282, Rv0285 and Rv0292 using primer sets Rv0282 pUAB300 f & 
Rv0282 pUAB300/400 r (Lane 2 and 5, ~1930bp), Rv0285 pUAB300 f & Rv0285 pUAB300/400 r (Lane 3 
and 6, ~325bp) and Rv0292 pUAB300 f & Rv0292 pUAB300/400 r (Lane 4 and 7, ~1050bp). Lane 1 is 
GeneRuler DNA Ladder Plus (Fermentas); Lane 2-4 M. smegmatis ESX-3ms KO + ESX-3mtb; Lane 5-7 M. 
smegmatis WT + ESX-3mtb 
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4.4.2. Secretion analysis of EsxH expressed from pUAB300 and pYUB412 
We investigated the expression of EsxH from the mycobacterial M-PFC expression vector pUAB300 and 
the pYUB412 cosmid containing the M. tuberculosis ESAT-6 gene cluster region 3. The whole cell lysates 
of the M. smegmatis WT and ESX-3ms KO cultures expressing ESX-3mtb and EsxH were separated by 
SDS-PAGE. The gels were stained with silver stain (Figure 4.2A) or analysed by Western blotting using a 
mouse anti-TB10.4 primary antibody and an HRP-conjugated goat anti-mouse secondary antibody to 
determine whether EsxH protein is expressed in these cultures (Figure 4.2B). Silver staining of the SDS-
PAGE gel showed that all of the WCLs contained a range of protein band sizes, and the TB10.4 protein 
control was present as two bands of just under 15 kDa. All six WCL samples contained protein bands of 
approximately this size. Western blotting of the duplicate gel strongly detected the TB10.4 positive control 
protein, however no EsxH protein was detected in any of the samples.  
 A       1      2      3      4      5      6       7       L             B   L        1      2       3             4       5      6      7      
           
3-18% SDS-PAGE 
Figure 4.2. EsxH was not detected in the M. smegmatis WCLs. A. SDS-PAGE of the WCL fractions of 
the M. smegmatis strains followed by Silver staining (A) and Western Blotting (B) showed that although 
the WCLs were rich in proteins of a range of sizes, no TB10.4 protein could be detected in any of the 
samples. L. PageRuler Prestained Protein Ladder (Fermentas), 1. M. smegmatis WT, 2. M. smegmatis 
WT + ESX-3mtb, 3. M. smegmatis WT + EsxGH, 4. M. smegmatis ESX-3ms KO, 5. M. smegmatis ESX-3mtb 
KO + ESX-3mtb, 6. M. smegmatis ESX-3ms KO + EsxGH, 7. TB10.4 positive control.  
No EsxH could be detected in the WCLs of any of the M. smegmatis wild-type or ESX-3ms knock-out 
strains with or without the esxG-esxH operon, although the recombinant TB10.4 positive control was 
detected by Western blotting. This suggests that there is no crossreactivity between the M. smegmatis 
Esx proteins and the TB10.4 primary antibody. It appears that expression of EsxH from the ESAT-6 gene 
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cluster region 3 contained in pYUB412_ESX3 as well as from pUAB300 was too low to be detected by 
Western Blotting. 
4.4.3. Construction of M. smegmatis strains for His-tagged EsxH secretion analysis 
In an attempt to express larger amounts of EsxH in M. smegmatis, and enable more sensitive detection 
thereof, in order to establish whether M. smegmatis ESX-3ms can secrete M. tuberculosis EsxH, we 
coexpressed EsxG and EsxH from the mycobacterial expression vector p19Kpro_EsxGH. The EsxH 
protein expressed from this vector contains a C-terminal Histidine tag to enable the protein to be enriched 
for from the WCL and CF. This vector was transformed into M. smegmatis WT and M. smegmatis ESX-3ms 
KO strains to produce M. smegmatis WT + EsxGH-His and M. smegmatis ESX-3ms KO + EsxGH-His, to 
determine whether M. smegmatis ESX-3ms is able to secrete M. tuberculosis EsxH. The genotypes of the 
transformants were confirmed by PCR (Figure 4.3). 
4.4.4. Secretion analysis of His-tagged EsxH from M. smegmatis WT and ESX-3ms KO 
strains 
M. smegmatis WT + EsxGH-His and M. smegmatis ESX-3ms KO + EsxGH-His strains were cultured and 
the His-tagged EsxH protein was enriched for from the WCLs using the MagneHis™ Protein Purification 
System. The purified  EsxH-His proteins were separated by SDS-PAGE. Silver staining detected a band in 
each of the WCL fractions, corresponding to the size of one of the TB10.4 positive control bands (Figure 
4.4A). Western blotting of a duplicate gel, using mouse anti-TB10.4 primary antibody and goat anti-mouse 
IgG-HRP secondary antibody detected only the TB10.4 positive control (Figure 4.4B). No His-tagged 
protein could be detected in the WCL fractions by reprobing with anti-His (C-terminal) primary antibody 
and goat anti-mouse IgG-HRP (horseradish peroxidase) secondary antibody, or the HisDetector™ HRP 
Colorimetric Western Blot Detection Kit (not shown). We predict that the level of expression of EsxH from 
p19Kpro is insufficient to allow detection of this protein by any of the Western blotting methods used and 
that the proteins observed by SDS-PAGE and silver staining after His purification are background. These 
results are supported by independent analyses by Mr Z. Fang looking at the expression of various His-
tagged M. tuberculosis proteins, including EsxG and EsxH from p19Kpro, where no His-tagged protein 
could be specifically detected by Western Blotting. 
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 As no EsxH, or His-tagged EsxH protein could be detected in any of the WCLs, no further analyses could 
be done.  
                        1      2        3        4       5        6       7       8        9         
                  A.  1.5% agarose gel in TAE                                                         
                               1      2       3        4       5       6       7       8       9 
                 B.   1.5% agarose gel in TAE                                                         
                        1        2       3       4        5       6        7      8       9 
                 C.   1.5% agarose gel in TAE                                                         
Figure 4.3. PCR confirmation of the M. smegmatis WT and ESX-3ms KO strains containing 
p19Kpro_EsxGH. Colonies were screened to confirm M. smegmatis WT + EsxGH-His (Lane 2-5) and M. 
smegmatis ESX-3ms KO + EsxGH-His (Lane 6-9). PCR was performed using the primersets (A.) R3 F1 f&r 
(798bp in WT), (B.) R3 KO f&r (820bp in ESX-3ms KO) and (C.) p19Kpro_EsxG sense & p19Kpro_EsxH 
antisense (654bp). Lane 1 contains GeneRuler 100bp DNA Ladder Plus (Fermentas). 
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                      L         1       2     3                                    L    1     2     3 
          A.           B.  
                    3-18% SDS-PAGE 
Figure 4.4. His-tagged EsxH was not detected in M. smegmatis WCLs. Although SDS-PAGE and 
silver staining detected proteins of the appropriate size for EsxH in the WCLs of both M. smegmatis WT 
and ESX-3ms KO containing p19Kpro_EsxGH-His (A), this protein could not be verified by Western blotting 
with antibodies against EsxH (B) or the His-tag (not shown). L. PageRuler Prestained Protein Ladder 
(Fermentas), 1. M.smegmatis WT + EsxGH-His, 2. M.smegmatis ESX-3ms KO + EsxGH-His, 3. TB10.4 
positive control.  
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4.5. Discussion 
This study aimed to determine whether the M. smegmatis ESX-3 secretion machinery is able to secrete M. 
tuberculosis EsxH protein, and thereby begin to establish whether the ESX-3 secretion system is 
functionally conserved between the two species. ESX-3 is essential in M. tuberculosis and cannot be 
deleted from the organism (Sassetti et al., 2003), therefore M. smegmatis and the M. smegmatis ESX-3ms 
KO are useful for the investigation of EsxH secretion by ESX-3. In addition the ease of manipulation of M. 
smegmatis and its rapid growth make it more convenient for analyses. By investigating the differential 
secretion of M. tuberculosis EsxH by M. smegmatis WT, ESX-3ms KO and strains complemented with the 
M. tuberculosis ESX-3 it could be determined whether M. smegmatis is able to secrete M. tuberculosis 
EsxH, whether the ESX-3 secretion system is responsible for the secretion of EsxH in M. smegmatis, and 
whether introduction of the M. tuberculosis ESX-3 secretion system in M. smegmatis can complement an 
absence of EsxH secretion from this species.  
EsxG and EsxH are coexpressed in vivo and interact to form a complex which is secreted (Okkels and 
Andersen, 2004). Therefore we coexpressed EsxG and EsxH in M. smegmatis to investigate the 
involvement of ESX-3 in EsxG-EsxH secretion by establishing the presence of EsxH (TB10.4) in the whole 
cell lysates and culture filtrates of M. smegmatis strains of various genotypes. However no EsxH could be 
detected in any of the samples, probably due to insufficient EsxH expression. Therefore we were unable 
to determine the ability of M. smegmatis ESX-3ms to secrete M. tuberculosis EsxH. Further investigations 
were not possible due to time constraints, however expression of EsxG and EsxH from an inducible vector 
may enable more effective detection EsxH and further analysis of its secretion. This will be investigated in 
further studies. 
Understanding the level of conservation of function of the ESX-3 between mycobacterial species, and its 
role in EsxH secretion may assist in establishing the M. smegmatis ESX-3ms KO as a useful model for the 
investigation of the functions of ESX-3, and to establish its essential role in M. tuberculosis. As ESX-3 is 
essential for M. tuberculosis survival and EsxH, which is highly expressed under low iron and zinc 
conditions (Rodriguez et al., 2002; Maciag et al., 2007), is a potent antigen (Skjot et al., 2000), this 
secretion system is an important topic for tuberculosis research and a greater understanding of which may 
lead to important advances in tuberculosis prevention and treatment. 
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Conclusion 
The M. tuberculosis ESAT-6 gene cluster region 3 encodes the machinery of a dedicated secretion 
system, ESX-3. This secretion system is essential for the survival of M. tuberculosis, therefore 
understanding its structure, function and substrates may lead to the identification of novel drug targets for 
the treatment of tuberculosis. 
In this study we have implemented a novel technique, Mycobacterial – Protein Fragment 
Complementation (Singh et al., 2006), to identify novel protein-protein interactions between the 
components of the ESX-3 secretion machinery. We identified several putative interactions and proposed a 
model of the mechanism of the ESX-3 secretion machinery based on these interactions, the putative 
functions of the proteins and the current knowledge of the ESX secretion systems. The Esx, PE and PPE 
proteins encoded in the ESAT-6 gene clusters are predicted to be secreted substrates of the ESX 
secretion machineries. We have shown that the EsxG-EsxH and PE5-PPE4 complexes have almost 
identical interactomes and are therefore probably secreted via the same secretion mechanism. In addition, 
the Esx proteins duplicated from those in the ESAT-6 gene cluster region 3 interact with EsxG and EsxH, 
and themselves, and therefore probably form additional substrates of the ESX-3 secretion machinery. 
We have also created a knock-out of the ESX-3ms secretion system in M. smegmatis, which will enable 
further investigation into the functions, substrates and mechanisms of this secretion system. As ESX-3 is 
essential in M. tuberculosis, the ESX-3ms knock-out of M. smegmatis is a valuable tool for the investigation 
of this secretion system.  
We attempted to investigate whether M. smegmatis is able to secrete M. tuberculosis EsxH and to assess 
the role of ESX-3ms in the secretion thereof, by comparing EsxH secretion by M. smegmatis WT and the 
M. smegmatis ESX-3ms KO. Unfortunately we were unable to detect any EsxH in these samples, probably 
due to inefficient expression of the proteins from the specific mycobacterial expression vectors that were 
used in this study. Understanding the conservation of function and mechanism of secretion of ESX-3 
between M. tuberculosis and M. smegmatis would assist in validating the extrapolation of any findings 
regarding ESX-3, from studies in M. smegmatis to the M. tuberculosis ESX-3 secretion system and also 
confirm the role of ESX-3 in EsxH secretion. 
 89 
Expression of the ESX-3 secretion machinery is upregulated under low iron and low zinc conditions 
(Rodriguez et al., 2002; Maciag et al., 2007). Mycobacteria employ two classes of siderophores for iron 
uptake; namely exochelins and mycobactins. M. smegmatis and other saprophytic mycobacteria produce 
both exochelins and mycobactins, however M. tuberculosis and other pathogenic bacteria produce only 
siderophores of the mycobactin class. A recent study by Siegrist et al. (2009) showed that ESX-3 is 
required for mycobactin utilisation in mycobacteria, allowing the uptake of iron from these scavenger 
molecules. This explains the disparity in the essentiality of ESX-3 in M. smegmatis and M. tuberculosis; 
while M. smegmatis can harvest iron from exochelins in the absence of ESX-3, M. tuberculosis is unable 
to acquire the iron necessary for its survival.  A conditional knock-out of ESX-3 in M. tuberculosis is able to 
survive in media with very high concentrations of zinc and iron, or with culture filtrate from wild-type M. 
smegmatis (Serafini et al., 2009). This suggests that ESX-3 is involved in the secretion of factors which 
allow for the uptake of mycobactin-scavenged iron into the mycobacterial cell. During infection iron is in 
demand from both the host and pathogen. The host sequesters iron to limit the amount available to the 
pathogen. Therefore the iron available to the infecting mycobacteria is severely limited. ESX-3 expression 
is upregulated under iron-poor conditions, leading to the increased secretion of factors involved in iron 
acquisition from mycobactin. EsxH, secreted by ESX-3, is a potent immunogen, consistent with the theory 
that secretion for ESX-3 is upregulated under iron-poor conditions during infection. Indeed, Siegrist et al. 
2009 showed that mycobacteria lacking ESX-3 are severely impaired during macrophage infection. 
The ESX-3 secretion system appears to play an important role in the survival of pathogenic mycobacteria, 
especially under iron-limiting conditions, as experienced in the host. In addition, the secretion system is 
required for infection. Therefore understanding this secretion system, its functions and substrates is 
essential to fully understand mycobacterial pathogenicity. We have identified interactions between 
components and substrates of this secretion system. These will assist in understanding the structure and 
function of this secretion system. In addition the M. smegmatis ESX-3ms knock-out will enable further 
studies to identify substrates and the specific functioning of the secretion system. This study has laid 
groundwork for future investigations into ESX-3, a better understanding of which may enable advances in 
the treatment and prevention of tuberculosis and hopefully assist in the eradication of the disease. 
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Future directions 
The protein-protein interactions between the components of the ESX-3 secretion machinery, identified in 
this study, need to be confirmed and validated using other techniques, possibly including in vivo pull down 
assays and Blue Native PAGE. As part of an international collaboration, additional studies are underway 
to identify protein-protein interactions from within the other 4 ESX secretion systems. Comparisons 
between the interactomes of the 5 ESX secretion systems may highlight similarities and differences 
between them. Interactions between components of different ESX secretion systems may also be 
investigated and enhance our understanding of the degree, if any, of complementation between them.  
Future studies aim to further understand these mycobacterial secretion systems, including 
- To investigate the evolutionary history of the type VII ESX secretion systems (T7SSs) by 
determining the presence and studying the function of these systems in different mycobacterial and 
other actinobacterial species. 
- To determine the regulation of the ESX secretion systems. 
-  To investigate the structure and secretion mechanism of the ESX secretion systems. 
- To identify and investigate novel substrates of the ESX secretion systems and to study their 
functions in the human host infection process.  
- To determine the role of the ESX systems in divalent-cation homeostasis and PE-PPE interactions 
in the mycobacteria. 
It is envisaged that these studies will allow us to better understand the functions of the five 
immunologically important ESX secretion systems of M. tuberculosis, thereby providing targets and 
biomarkers for future diagnostic, drug and vaccine design and facilitate in the eradication of tuberculosis 
disease.
ADDENDUM A 
 
Materials and Methods 
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1. Bacterial strains 
E. coli JM109 (laboratory strain) and K12 ER2925 (NEB) and M. smegmatis mc2155 (Snapper et al., 
1990) are used as described in each study (Table A1). 
2. Media and culture conditions  
Culture media are described in Table A2. Antibiotics and supplements are described in Table A3. 
E. coli is cultured in liquid Luria-Bertani broth (LB) with shaking, and on LB agar plates, overnight at 37 °C.  
Solid and liquid media are supplemented with antibiotics; ampicillin (50 ug/ml), kanamycin (50 ug/ml) and 
hygromycin (100 ug/ml); and solid media with 5-bromo-4-chloro-3-indolyl-β-galactoside (X-gal) and 
isopropyl-β-D-thiogalactopyranoside (IPTG); as appropriate. 
M. smegmatis is routinely grown in Middlebrook 7H9 Broth with shaking, and on BBLTM Seven H11 Agar 
Base plates, at 37 °C for 2-3 days unless otherwise described. For knock-out construction M. smegmatis 
is grown in LB with 0.1% Tween-80 and on LB agar, and for secretion studies M. smegmatis is grown in 
Kirchener’s broth. Kanamycin (25 ug/ml), hygromycin (50 ug/ml) and trimethoprim (15-50 ug/ml), sucrose 
(5%) and X-gal are added as appropriate. 
Bacterial strains used in this study are stored in 40% glycerol at -80 °C. 
3.  Ziehl-Neelsen Staining 
M. smegmatis cultures are screened for contamination using Ziehl-Neelsen (ZN) staining according to 
standard protocol as outlined by Kent and Kubica (1985). Briefly, aliquots of M. smegmatis cultures are 
heat-fixed to microscope slides. Slides are flooded with ZN Carbol Fuschin, heated intermittently with a 
flame until steaming, and allowed to stand for 5 minutes. Slides are rinsed with water, decolourised with 
5% acid-alcohol solution for 2 minutes and rinsed with water. Slides are then counterstained with 
Methylene Blue for 1-2 minutes, rinsed with water and allowed to air dry. Slides are read using a light 
microscope under the 100X (oil immersion) lens. Uncontaminated M. smegmatis cultures will contain only 
acid fast bacilli (pink rods). 
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Table A1. Bacterial Strains 
Strain Genotype Features Reference/Source 
E. coli JM109 recA1, endA1, gyrA96, thi, hsdR17, supE44, relA1, 
∆(lac-proAB)/F' [traD36, proAB+, lacIq, lacZ∆M15 
Chloramphenicol resistance  
Methylation: dam+, dcm+ 
Blue-white selection + 
Laboratory strain 
E. coli  K12 ER2925 ara-14 leuB6 fhuA31 lacY1 tsx78 glnV44 galK2 galT22 
mcrA dcm-6 hisG4 rfbD1 R(zgb210::Tn10)TetS endA1 
rpsL136 dam13::Tn9 xylA-5 mtl-1 thi-1 mcrB1 hsdR2 
Tetracycline resistance 
Methylation: dam- , dcm- 
Blue-white selection - 
New England Biolabs 
M. smegmatis mc²155 ept-1 Efficient plasmid transformation 
mutant of M. smegmatis mc²6 
Mycobacterial model organism 
Snapper et al. 1990 
 
 
Table A2. Culture media 
Medium Composition Source 
Luria-Bertani broth (LB) 1% Tryptone, 0.5% Sodium chloride, 0.5% Yeast extract   
Luria-Bertani agar (LB agar) 1% Tryptone, 0.5% Sodium chloride, 0.5% Yeast extract, 1.2% 
bacteriological agar 
 
SOB 2% Tryptone, 0.5% Sodium chloride, 0.5% Yeast extract, 2.5 mM Potassium 
chloride,  
 
SOC SOC supplemented with 20 mM glucose and 10 mM Magnesium chloride 
after autoclaving 
 
Middlebrook 7H9 Broth (7H9) 0.47% Middlebrook 7H9 Broth powder, supplemented with 0.5% glycerol, 
0.5% glucose, 0.2% Tween-80 after autoclaving 
Becton Dickinson 
(BD) 
BBLTM Seven H11 Agar Base (7H11) 1.9% BBLTM Seven H11 Agar Base powder, supplemented with 0.5% 
glycerol, 0.5% glucose, 0.2% Tween-80 after autoclaving 
Becton Dickinson 
(BD) 
Kirchener's Broth 0.5% asparagine, 0.3% DiSodium hydrogen phosphate, 0.4% Potassium 
dihydrogen phosphate, 0.25% Trisodium citrate, 0.107% Magnesium 
sulphate, 2% glycerol 
  
All media was prepared in deionised water and autoclaved at 121 °C for 20 minutes. Concentrations of all dry components are given as % m/v, and 
liquids as % v/v.  
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Table A3. Antibiotics and supplements 
 
Stock 
concentration 
Solvent Sterilisation Storage Supplier Working concentration 
      E. coli M. smegmatis 
Ampicillin (amp) 50 mg/ml Deionised water filtered -20 °C Roche 50 ug/ml n/a 
Chloramphenicol (cam) 34 mg/ml Ethanol  4 °C Roche 25 ug/ml n/a 
Hygromycin* (hyg) 50 mg/ml  Phosphate buffered 
saline (PBS) 
filtered 4 °C Invitrogen 100 ug/ml 50 ug/ml 
Kanamycin* (kan) 50 mg/ml  0.9% NaCl solution filtered 4 °C Sigma 50 ug/ml 25 ug/ml 
Tetracycline (tet) 5 mg/ml Ethanol  -20 °C Sigma 50 ug/ml n/a 
Trimethoprim (trim) 50 mg/ml DiMethyl Sulfoxide 
(DMSO) 
filtered use fresh Sigma n/a 15-50 ug/ml 
        
5-bromo-4-chloro-3-indolyl-β-
galactoside (X-gal) 
20 mg/ml N,N'-dimethyl formamide  -20 °C,  
in foil 
Roche 100 ul spread on 90 mm 
plate 
Isopropyl-β-D-
thiogalactopyranoside  (IPTG) 
0.1M Deionised water filtered -20 °C Biosolve 100 ul spread on 90 mm 
plate 
Potassium Chloride (KCl) 1M Deionised water autoclaved, 
121°C, 20min 
RT Merck   
Magnesium Chloride* (MgCl2) 1M Deionised water filtered RT Sigma   
Glucose  1M Deionised water filtered -20 °C Merck   
Glucose 50% v/v Deionised water filtered 4 °C Merck  0.5% v/v 
Glycerol 50% v/v Deionised water filtered 4 °C Merck  0.5% v/v 
Polyoxyethylene-sorbitan 
monooleate (Tween 80) 
20% v/v Deionised water filtered 4 °C Sigma  0.2% v/v 
Sucrose 50% v/v Deionised water filtered 4 °C Merck  5% v/v 
*Supplements and antibiotics purchased in solution  
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4. DNA manipulation 
4.1. DNA and protein sequence analyses 
All M. tuberculosis DNA and protein sequence information is obtained from the M. tuberculosis H37Rv 
genome sequence database (Tuberculist, http://genolist.pasteur.fr/TubercuList/index.html). The M. 
smegmatis DNA sequence is obtained from the JVCI CMR Mycobacterium smegmatis MC2 Genome 
Page (http://cmr.jcvi.org/tigr-scripts/CMR/GenomePage.cgi?org=gms). 
4.2. Primer design 
Primers are designed using Primer Premier 5.0 (PREMIER Biosoft International) and obtained from 
Integrated DNA Technologies (IDT, through Whitehead Scientific, www.whitesci.co.za). Appropriate 
restriction endonuclease cutting sites are incorporated as necessary to facilitate in-frame cloning 
procedures. Primer sequences and details are given in each study.  
4.3. PCR amplification 
FastStart Taq DNA Polymerase (Roche) is used for PCR amplification using the GC-rich buffer, as 
described by the manufacturer. Annealing temperatures (Tm) appropriate for each primer set are given in 
each study and elongation times calculated at 1 minute per 1kb. Thirty-five cycles are used unless 
otherwise stated. 
4.4. Restriction Digestion 
Plasmid DNA is digested using restriction endonucleases as per manufacturers instructions, using the 
appropriate buffers. 2-5 ug of plasmid DNA is digested using 10U of enzyme in a total volume of 10-20 ul 
for 2-5 hours at 37 °C. All restriction endonucleases are obtained from New England Biolabs (NEB), 
Promega or Fermentas. 
4.5. Agarose gel electrophoresis 
PCR products and restriction digests are separated by electrophoresis at 80V on 1.0 to 1.5% agarose gels 
in TAE buffer (40 mM Tris, 20 mM Acetic acid, 1 mM Ethylenediamine tetraacetic acid (EDTA)) with 
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ethidium bromide and visualized using UV light. The GeneRulerTM 100bp DNA Ladder Plus, ready-to-use 
(Fermentas) is used to determine band size. When necessary the resultant bands are excised from the gel 
and purified.  
4.6. DNA clean-up 
The Wizard® SV Gel and PCR Clean-up System (Promega) is used to purify DNA embedded in agarose 
gel slices and directly from a PCR or restriction endonuclease reaction. 
4.7. DNA quantification 
DNA is quantified using the NanoDrop®  ND1000 Spectrophotometer. 
4.8. DNA sequencing 
Automated sequencing is done by the Central Analytical Facility (CAF) at Stellenbosch University, using 
the ABI 3130XL Genetic Analyzer (Applied Biosystems).   
4.9. Cloning vectors 
All inserts are cloned into the commercial T-vector, pGem-T-easy (Promega), and subcloned into the 
relevant expression and suicide vectors, as described in each study. 
4.10. Dephosphorylation 
Linearized vectors are dephosphorylated using Shrimp Alkaline Phosphatase (SAP, Roche) to prevent 
self-ligation of the digested plasmids.  One unit of SAP is added to digested vector DNA with the 
appropriate buffers, according to the manufacturer’s instructions. The reaction is incubated for 10 minutes 
at 37 °C, followed by deactivation for 15 minutes at 65 °C.  
4.11. Ligations 
PCR and restriction digest products are ligated into appropriate vectors using T4 DNA Ligase (Promega), 
according to manufacturer’s instructions.  Inserts are ligated into 100 ng of vector at an insert:vector molar 
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ratio of 3:1 using 3u of T4 DNA Ligase, and incubated at 4 °C overnight.  Ligation reactions are 
deactivated at 70 °C for 10 minutes prior to electrotransformation. 
4.12. Transformations 
All transformations of E. coli and M. smegmatis are by electroporation of electrocompetent cells, as 
described below, using the Gene PulserTM (Bio-Rad) in 0.2 cm Gene Pulser® Cuvettes (Bio-Rad). 
4.13. Colony PCR 
All transformants are confirmed by colony PCR using 1 ul culture in a 12.5 ul PCR reaction as described 
under PCR amplification. 
4.14. Miniprep plasmid isolation 
Plasmid DNA is isolated from E. coli using the Wizard® Plus SV Minipreps DNA Purification System 
(Promega), according to manufacturers instructions, and eluted in 50 ul nuclease-free water (Promega). 
5. Cloning 
Inserts are amplified by PCR using specific PCR primers. The PCR products are separated by 
electrophoresis, purified and ligated into pGem-T-Easy according to manufacturer’s instructions. The 
ligation mixture is transformed into competent E. coli  and selected for on appropriate LB agar. Colonies 
are picked and inoculated into LB media. Colony PCRs are done to confirm the insert and the construct 
was isolated. The resultant constructs are sequenced using Sp6 and T7 primers to confirm the sequence 
of the inserts. 
The constructs are digested using the primer-specific restriction endonucleases and the inserts separated 
by electrophoresis, cut from the gel and purified. The purified inserts are ligated into the pre-digested 
expression or suicide vectors, as appropriate, and transformed into E. coli. Transformed colonies are 
picked, colony PCR done and the constructs isolated and sequenced to verify the sequence and frame of 
relevant inserts.  
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6. Preparation of electrocompetent cells 
6.1. Electrocompetent E. coli  
E. coli JM109 or K12 ER2529 cells are inoculated into 50 ml LB containing tetracycline (50 ug/ml) or 
chloramphenicol (25 ug/ml), respectively, and shaken overnight at 37ºC. Overnight cultures are inoculated 
into fresh antibiotic-containing medium, at a dilution of 1:100, and grown to  OD600 = 0.7 at 37ºC, with 
shaking. Cultures are placed on ice and all further steps performed under ice-cold conditions. Cells are 
harvested by centrifugation at 5000 rpm for 10 minutes at 4ºC. The cell pellet is resuspended in an equal 
culture-volume of ice-cold 10% glycerol and centrifuged at 5000 rpm for 10 minutes at 4ºC. The wash step 
is repeated and the cells pooled in a 50 ml falcon tube and centrifuged at 4000 rpm for 10 minutes at 4ºC. 
The cells are resuspended in ice-cold 10% glycerol using a volume of 2 ml per liter of culture. Aliquots of 
100 ul are prepared, frozen in liquid nitrogen and stored at -80ºC. 
6.2. Electrocompetent M. smegmatis 
M. smegmatis mc2155 cells are inoculated into Middlebrook 7H9 medium and grown to OD600 = 0.5, at 
37ºC with shaking. Cultures are incubated on ice for 1 hour and all further steps performed under ice-cold 
conditions. Cells are pelleted by centrifugation at 4000 rpm for 10 minutes at 4ºC, resuspended in ice-cold 
10% glycerol equal to the culture volume and pelleted. The wash step is repeated and the cells 
resuspended in ice-cold 10% glycerol using a volume of 2 ml per 100 ml of culture. Electrocompetent M. 
smegmatis is freshly prepared before use. 
7. Electroporation 
7.1. E. coli electroporation 
E. coli is transformed at 2.5 kV, 25 µF, 125µ Fd, 200 Ώ using 2 ul of a 10 ul ligation reaction, or 1 ug of 
plasmid DNA, in 45 ul of electrocompetent cells. One milliliter of SOC is added to the transformed cells 
which are expressed for 30-60 minutes at 37 °C before plating on appropriate solid media.  
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7.2. M. smegmatis electroporation 
One microgram of purified plasmid DNA is transformed into 200 ul of electrocompetent M. smegmatis at 
2.5 kV, 25 µF, 125 µFd, 1000 Ώ followed by the addition of 1 ml 7H9 medium and expression for 3 hours 
at 37 °C before plating on appropriate solid medium. 
8. Protein analyses 
8.1. Culture fractionation 
M. smegmatis cultures are separated into cell pellet and culture supernatant by centrifugation at 4000 rpm 
for 15 minutes at 4 °C. All subsequent steps are performed on ice.  
8.1.1. Culture filtrate protein precipitation 
The culture supernatant is filtered consecutively through 0.45 um and 0.22 um syringe filters. Four 
volumes of ice cold acetone is added to the culture filtrate, and incubated at -20 °C overnight. The culture 
filtrate proteins are precipitated by centrifugation at 14 000 rpm for 15 minutes at 4 °C.  The supernatant is 
discarded and the protein pellet stored at -80 °C. The pellet is resuspended in phosphate-buffered saline 
(PBS) prior to use. 
8.1.2. Whole cell lysate 
The cell pellet is resuspended in 1 ml ice cold PBS and transferred to a 2 ml ribolyser tube. The sample is 
centrifuged at 14 000 rpm at 4 °C for 10 minutes, and the supernatant discarded. A volume of 0.1 mm 
silica beads equal to the volume of the cell pellet, and 500ul ice cold PBS are added to the tube. The cells 
are mechanically lysed by ribolysing in a BIO 101/Savant FastPrep FP120, 6 times for 20 seconds at 
maximum speed, with 1 minute intervals on ice. The samples are incubated on ice for 5 minutes and 
centrifuged for 10 minutes at 14 000 rpm at 4 °C. The supernatant, containing the whole cell lysate, is 
filtered through a 0.22 um syringe filter and stored at -80 °C. 
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8.2. Purification of His-tagged proteins from Whole Cell Lysate 
The MagneHis™ Protein Purification System (Promega) is used, essentially as described by the 
manufacturers, to purify the His-tagged proteins from M. smegmatis cells. Cultures are fractionated and 
the cell lysate prepared as described in 8.1 in MagneHis Binding/Wash Buffer. Two microliters of 
preprepared DNase I is added to each sample and incubated, with shaking, for 30 minutes. The sample is 
centrifuged at 4000 rpm for 10 minutes and the supernatant removed. NaCl is added to each sample at 
final concentration of 500 mM. Thirty microliters of MagneHis Ni-Particles are added to each 1 ml sample 
and mixed by inverting 10 times.  The samples are incubated at room temperature for 5 minutes to allow 
protein binding to the Nickel beads. The samples are placed in a magnetic stand for 30 seconds to 
capture the beads, and the supernatant removed. The beads are washed three times with MagneHis 
Binding/Wash Buffer (with 500 mM NaCl): 150 ul of Wash buffer is added to the sample and mixed by 
pipetting, the sample is placed in the magnetic stand for 30 seconds and the supernatant removed. The 
His-tagged proteins are eluted by adding 100µl of MagneHis Elution Buffer to the beads, pipetting to mix, 
and incubating at room temperature for 2 minutes. The tubes are placed in the magnetic stand, to capture 
the beads, and the supernatant, containing His-tagged proteins removed and stored at -20 °C for future 
applications.  
8.3. Protein concentration determination 
The protein concentrations of samples are determined spectrophotometrically using the Bio-Rad Protein 
Assay with the 1 x Quick Start™ Bradford Dye Reagent (Bio-rad), according to standard microtiter plate 
procedure, as described by the manufacturer,. The Quick Start™ Bovine Serum Albumin Standard Set 
(BSA concentration range 0.125 mg/ml – 2 mg/ml) is used to generate a standard curve. 
Protein samples are measured in undiluted, 1:10 and 1:100 dilutions, in duplicate. Standards are 
measured in triplicate. Ten microliters of each sample and standard are pipetted into separate microtiter 
wells. Two hundred microliters of Dye Reagent is added to each well, and mixed. The samples are 
incubated at room temperature for 5 minutes. Absorbance is measured at 595 nm (read within 1 hour). 
A standard curve is plotted from the BSA standard absorbance readings, and sample concentrations 
determined from the standard curve. 
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8.4. SDS-PAGE 
All reagents and buffers used for SDS-PAGE are described in Table A4 and A5. 
8.4.1. Sample preparation 
An equal volume of 2 x SDS Sample Buffer was added to each protein sample (maximum total volume per 
well is 20 ul). The sample is mixed and incubated at 100 °C for 5 minutes.  
8.4.2. Gel preparation 
The gel apparatus is prepared according to manufacturer’s instructions. The apparatus is filled with water 
to check for leakage. 
The separating gel is prepared according to Table A6 and poured into the gel apparatus. Isopropanol is 
added to the surface of the gel to remove bubbles and level the surface of the gel. Allow 20 minutes for 
the gel to set, pour off the isopropanol and rinse the gel surface with Stacking buffer. 
Prepare stacking gel according to Table A6 and pour over separating gel until gel is overfull. Insert comb.  
Allow gel to set for 20 minutes.  
 
8.4.3. Electrophoresis 
Remove gel from setting apparatus and place in running chamber. Pour running buffer into upper and 
lower chambers to cover top and bottom of gel, and both electrodes. Remove comb. Load 15-20 ul of 
samples into wells, including molecular weight marker. 
Electrophorese at 100 V until samples enter separating gel, increase voltage to 150 V and run until the 
dye front reaches the end of the gel.  
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Table A4. SDS-PAGE reagents 
Reagent   concentration Diluent Storage Source 
20% SDS Sodium dodecyl sulphate 20% m/v  Water RT Sigma 
10% SDS Sodium dodecyl sulphate 10% m/v  Water RT Sigma 
EDTA Ethylenediaminetetraacetic acid 0.5 M Water RT Fluka 
Bromophenol blue  0.75% m/v Water RT Fluka 
APS Ammonium persulphate 10% m/v  Water 4 °C Sigma 
Acrylamide/bisacrylamide  30:0.8% m/v Water 4 °C, in dark container Bio-rad 
TEMED N,N,N',N'-Tetramethylethylenediamine   RT, in dark container Sigma 
β-Mercaptoethanol    RT, in dark container Merck 
Glycine    RT Merck 
Tris tris(hydroxymethyl)aminomethane   RT Merck 
PageRuler™ Prestained Protein Ladder       -20 °C Fermentas 
Table A5. SDS-PAGE buffers 
Buffer Component Volume/concentration Diluent Storage pH 
Separating buffer Tris 1.5 M Water RT pH 8.8 (adjust with HCl) 
Stacking buffer Tris 1.0 M Water RT pH 6.8 (adjust with HCl) 
2x SDS Sample buffer Stacking buffer 3.4 ml    -20 °C or 4 °C   
 Glycerol 2 ml    
 20% SDS 3 ml    
 Bromophenol blue 500 ul    
 EDTA 200 ul    
 β-Mercaptoethanol 1 ml       
Running buffer Tris 25 mM Water 4 °C, or RT   
(do not adjust pH) Glycine 192 mM    
  SDS 0.1% m/v       
Table A6. SDS-PAGE gel composition 
Component 18% Separating gel (2 x 0.75 mm mini-slab gels) Stacking gel (4 x 0.75 mm mini-slab gels) 
Acrylamide/bisacrylamide 6.0 ml 1.3 ml 
Separating buffer 2.5 ml  
Stacking buffer  1.25 ml 
10% SDS 0.1 ml 0.1 ml 
TEMED 10 ul 20 ul 
APS 50 ul 50 ul 
Water fill to 10 ml fill to 10 ml 
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8.5. Silver staining 
Silver staining was done as described by Gromova et al. (2006). Buffers used for silver staining are 
described in Table A7. 
Soak SDS-PAGE gel in fixation solution for 2 hours, or overnight. Discard fixation solution and wash the 
gel in washing solution for 20 minutes, replacing the washing solution 3 times. Discard washing solution 
and shake gently in sensitizing solution for 2 minutes. Discard sensitizing solution and wash gel twice with 
pre-chilled deionised water for one minute. Discard water and add cold silver nitrate staining solution (add 
the solution to the corner of the tray and not directly onto the gel). Shake for 1 hour at 4 °C. Pour off the 
staining solution and rinse the gel twice with deionised water for 1 minute. Rinse gel in developing 
solution, discard and develop protein image in fresh developing solution for 2 - 5 minutes. Stop the 
reaction by adding terminating solution directly to the gel in the developing solution. Gently shake the gel 
in solution for about 10 minutes until the solution stops bubbling. 
8.6. Western Blotting 
Western Blotting is done as described by Gey van Pittius (2005). Buffers used in Western Blotting are 
described in Table A8.  
8.6.1. Protein transfer 
Presoak 2 western blot pads, 2 Whatmann 3M sheets and 1 HybondC-extra nitrocellulose or Hybond-P 
PVDF membrane in transfer buffer. When electrophoresis is completed, stack the following items onto the 
black side of the blotting apparatus sandwich, in transfer buffer: pad, Whatmann sheet, gel, membrane, 
Whatmann sheet, pad. Close sandwich and insert into Western blot apparatus with an ice pack and fill 
with cold transfer buffer. Add magnetic stirrer bar to chamber and place on magnetic stirrer in coldroom. 
Apply 100 V for 1 hour. Buffer becomes milky with air bubbles when current is flowing.  
Dismantle apparatus and check transfer by staining with Ponceau Red dye. The membrane is rinsed twice 
in distilled water, Ponceau Red dye added, and gently rotated for 5 minutes. The dye is retained for future 
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use, the membrane rinsed in distilled water and the protein bands observed. The dye is rinsed from the 
membrane with distilled water. 
The membrane is blocked overnight in 10% Blocking buffer. 
8.6.2. Western detection 
The blocked membrane is rinsed twice in TBS-T, and washed 3 times for 10 minutes in TBS-T buffer with 
shaking. Five milliliters of primary antibody, at the appropriate dilution, is added to the membrane and 
rotated at room temperature for 3 hours (Primary antibody may be retained and reused several times). 
The membrane is rinsed twice in TBS-T, and washed 3 times for 10 minutes in TBS-T buffer with shaking. 
The membrane is then probed with 5 ml secondary antibody for 1 hour at room temperature, washed as 
before and placed in a sealable plastic bag.  
The membrane is incubated in ECL detection fluid (ECL Plus Western Blotting Detection System, 
Amersham™) according to manufacturers instructions. The detection fluid is removed, the membrane 
attached to a piece of Whatmann paper and placed in a cassette. Signal is detected for 1-10 minutes on 
with autoradiographic film. 
Membranes can be stripped once in preheated stripping buffer in a 50 °C shaking water bath for 30 
minutes, washed twice in TBS-T at room temperature and reblocked in blocking buffer, followed by 
Western detection with an additional probe. 
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Table A7. Silver staining solutions 
Solution Component Source Diluent storage 
Fixation solution 50% ethanol Merck water RT 
 12% acetic acid Merck   
  0.05% formalin Merck     
Washing solution 20% ethanol Merck water RT 
Sensitizing solution 0.02% m/v sodium thiosulfate Sigma water RT 
Staining solution 0.2% m/v silver nitrate Sigma water prepare fresh 
  0.076%formalin Merck   precool to 4 °C before use 
Developing solution 6% m/v sodium carbonate Merck water RT 
 0.0004% sodium thiosulphate Sigma   
  0.05% formalin Merck     
Terminating solution 12% acetic acid Merck water RT 
Drying solution 20% ethanol Merck water RT 
 
Table A8. Western blotting buffers 
Buffer Composition Diluent pH Storage 
Transfer buffer 25 mM Tris Water pH should be 8.3; do not adjust 4 °C 
 192 mM Glycine    
  20% Methanol       
TBS-T 20 mM Tris (pH 7.6) Water   RT 
 137 mM NaCl    
  0.1% Tween-20       
Blocking buffer 10% m/v fat free milk powder TBS-T   RT 
 1% m/v Bovine serum albumin    
  10 mM Azide       
Stripping buffer 100 mM β-Mercaptoethanol Water  RT 
 2% m/v SDS    
  62.5 mM Tris (pH6.7)       
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